Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E21.34 EPS (ttm)6.53 Insider Own0.10% Shs Outstand759.61M Perf Week1.41%
Market Cap105.84B Forward P/E15.51 EPS next Y8.98 Insider Trans-4.40% Shs Float758.78M Perf Month4.92%
Income5.01B PEG2.15 EPS next Q2.10 Inst Own81.60% Short Float1.56% Perf Quarter19.94%
Sales19.46B P/S5.44 EPS this Y20.30% Inst Trans-1.05% Short Ratio3.85 Perf Half Y9.91%
Book/sh32.12 P/B4.34 EPS next Y6.89% ROA7.70% Target Price144.00 Perf Year20.66%
Cash/sh34.48 P/C4.04 EPS next 5Y9.90% ROE22.00% 52W Range104.22 - 139.93 Perf YTD23.43%
Dividend2.44 P/FCF22.72 EPS past 5Y12.00% ROI10.50% 52W High-0.43% Beta0.55
Dividend %1.75% Quick Ratio4.00 Sales past 5Y4.50% Gross Margin80.50% 52W Low33.69% ATR2.21
Employees20000 Current Ratio4.40 Sales Q/Q10.70% Oper. Margin33.80% RSI (14)67.57 Volatility1.60% 1.41%
OptionableYes Debt/Eq1.37 EPS Q/Q21.80% Profit Margin25.70% Rel Volume0.78 Prev Close137.97
ShortableYes LT Debt/Eq1.26 EarningsOct 20 AMC Payout32.60% Avg Volume3.08M Price139.33
Recom2.30 SMA201.87% SMA508.19% SMA20016.10% Volume2,398,900 Change0.99%
08-Sep-14Reiterated RBC Capital Mkts Outperform $138 → $150
04-Aug-14Reiterated Argus Buy $135 → $140
30-Jul-14Reiterated RBC Capital Mkts Outperform $125 → $138
18-Jul-14Reiterated Deutsche Bank Buy $144 → $149
23-Apr-14Reiterated Oppenheimer Perform $121 → $122
21-Mar-14Reiterated Barclays Equal Weight $115 → $130
31-Jan-14Reiterated Argus Buy $130 → $135
20-Nov-13Reiterated Deutsche Bank Buy $138 → $142
29-Aug-13Reiterated UBS Buy $121 → $124
27-Aug-13Reiterated Barclays Overweight $105 → $115
31-Jul-13Reiterated Oppenheimer Perform $100 → $109
24-Apr-13Reiterated Deutsche Bank Buy $108 → $115
15-Apr-13Reiterated Barclays Equal Weight $90 → $105
08-Apr-13Reiterated RBC Capital Mkts Outperform $95 → $105
25-Jan-13Upgrade Argus Hold → Buy $96
24-Jan-13Reiterated UBS Buy $96 → $98
12-Sep-12Downgrade Robert W. Baird Outperform → Neutral $84
10-Sep-12Upgrade UBS Neutral → Buy $80 → $96
02-Aug-12Downgrade Argus Buy → Hold
15-Mar-12Resumed Stifel Nicolaus Hold
15-Sep-14 05:06PM  Biotech still place to be: Pro CNBC
04:50PM  Biogen/AbbVie Report Positive Data on MS Drug Zinbryta Zacks
04:30PM  Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis PR Newswire
04:00PM  New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density PR Newswire
09:30AM  A Fabulous Pharma ETF ETF Trends
14-Sep-14 09:00PM  Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure PR Newswire
11-Sep-14 05:41PM  Medivation Eyes Blockbuster As Cancer Drug Gets An OK at Investor's Business Daily
03:30PM  Orexigen's Obesity Drug Contrave Approved by the FDA Zacks
09:20AM  Short Sellers Remain Vigilant Against Biotechs at 24/7 Wall St.
08:54AM  UPDATE: Morgan Stanley Reiterates On Amgen, Inc. Following Healthcare Conference Benzinga
07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
10-Sep-14 06:20PM  [video] Marathon Oil, Amgen Smart Long Haul Stocks Says Forester Fund Manager at TheStreet
04:20PM  Spectrum Pharmaceuticals to Advance Neutropenia Drug Zacks
04:06PM  Amgen, Inc. Showing More Upside Potential Benzinga
03:55PM  Xenoport/NIAAA Collaborate on Alcoholism Therapy Zacks
02:00PM  Myriad Genetics Posts Encouraging myPath Melanoma Data Zacks
10:17AM  Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Zacks
09:18AM  Zacks Rank #1 Additions for Wednesday Zacks
09:15AM  Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting PR Newswire
08-Sep-14 01:10PM  Five Reason Amgen Won't Be Breaking Up at Barrons.com
05-Sep-14 04:04PM  Amgen To Present At The Morgan Stanley Global Healthcare Conference PR Newswire
09:27AM  Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding Benzinga
04-Sep-14 05:00PM  Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab Zacks
11:01AM  Celgene: Good Data But What About the Patent Challenges? at Barrons.com
03-Sep-14 05:40PM  Sanofi Reports Positive Phase III Data on Dengue Vaccine Zacks
04:20PM  Arena Pharmaceuticals' APD811 Gets Orphan Drug Status Zacks
09:10AM  Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor Zacks
02-Sep-14 07:36PM  Biotech Helps Drive Broad Market at Investor's Business Daily
05:39PM  Today's Thorns, Roses and All Time Highs in the Markets... Yahoo Finance Blogs
03:44PM  [video] The cholesterol race at CNBC
03:04PM  [video] Jim Cramer Says Regeneron is a Better Way to Play it Than Sanofi at TheStreet
01:34PM  [video] Biotech's $10 billion opportunity at CNBC
01:00PM  [video] American doctor tests for Ebola: Report at CNBC
11:19AM  Novartis, Regeneron Hit New Highs On Cardio Drugs at Investor's Business Daily
08:17AM  [video] Race for cholesterol drugs at CNBC
08:15AM  Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency PR Newswire
08:00AM  Amgen Submits Marketing Authorization Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The European Medicines Agency PR Newswire
31-Aug-14 10:30AM  Study raises concerns over Servier, Amgen heart drug Reuters
03:00AM  Early data suggest Sanofi, Regeneron drug may halve heart risk Reuters
30-Aug-14 08:31AM  The Most Interesting Man Revolutionizing The Health World at Forbes
07:00AM  New Novartis Drug Effective in Treating Heart Failure at New York Times
28-Aug-14 06:42PM  Amgen edges up on trial results Investor's Business Daily
05:20PM  Amgen's Chronic Heart Failure Drug Gets Priority Review Zacks
03:17PM  Amgen: Why Its New Drug Application is a Big Deal at Barrons.com
03:17PM  Amgen: Why Its New Drug Application is a Bid Deal at Barrons.com
12:08PM  Amgen seeks U.S. approval of new cholesterol-fighting drug Reuters
09:45AM  Amgen submits U.S. application to sell cholesterol-fighting drug Reuters
09:15AM  Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol PR Newswire
09:00AM  Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA PR Newswire
08:31AM  BioDelivery Sciences (BDSI) Jumps: Stock Moves 5.6% Higher Zacks
27-Aug-14 11:45AM  Who are Amgen Inc.'s (AMGN) main competitors? at Investopedia
10:32AM  Why Amgen (AMGN) Stock Hit a One-Year High Today at TheStreet
10:12AM  [$$] Amgen Heart Drug Gets FDA Priority at The Wall Street Journal
09:15AM  FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure PR Newswire
26-Aug-14 05:44PM  Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study Zacks
05:00AM  'Fast Money' Recap: Next Stop, S&P 2,100? at TheStreet
25-Aug-14 09:49AM  [video] Gilead 'the drug story': Cramer at CNBC
22-Aug-14 03:40PM  Amgen Upgraded to Strong Buy Zacks
21-Aug-14 01:20PM  Lilly psoriasis drug impresses; battle nears with Amgen, Novartis Reuters
08:55AM  Lilly psoriasis drug fares well in late-stage test AP
20-Aug-14 03:27PM  Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy Zacks
10:08AM  Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus Zacks
19-Aug-14 04:25PM  Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 Zacks
09:50AM  A New Cannabinoid-based Arthritis Therapy in the Making Accesswire
08:55AM  Amgen parathyroid drug succeeds in late-stage trial (Aug 18) Reuters
08:07AM  Morning Movers: Home Depot Jumps on Big Beat; Aeropostale Climbs on New CEO at Barrons.com
07:07AM  [video] Hot biotech drugs at CNBC
01:55AM  Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company PR Newswire
18-Aug-14 11:21PM  Nasdaq hits highest level since March 2000 at USA TODAY
05:55PM  Amgen thyroid drug succeeds in late-stage trial Reuters
05:17PM  Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis PR Newswire
04:10PM  Ligand Up on Multi-Program Captisol Deal with Avion Pharma Zacks
03:35PM  4 Large-Cap Healthcare Stocks To Watch at Investopedia
15-Aug-14 08:03AM  The Zacks Analyst Blog Highlights: Amgen, ANN, Citi Trends, Men's Wearhouse and Kate Spade Zacks
12:00AM  Amgen Market Value Playing Catch-Up to Shares: Chart of the Day at Bloomberg
14-Aug-14 05:39PM  The New Large Cap All Time Highs... Yahoo Finance Blogs
04:25PM  Stocks End With Small Gains; Amgen Shrugs Off Drug Data at Investor's Business Daily
04:20PM  Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails Zacks
03:41PM  Amgen: Why No One Cares About Kyprolis Trial Failure at Barrons.com
03:10PM  [video] Red hot biotech stocks at CNBC
11:17AM  Trade-Ideas: Amgen (AMGN) Is Today's "Barbarian At The Gate" Stock at TheStreet
10:09AM  US STOCKS-Wall St edges up after Putin comments, Cisco falls Reuters
10:00AM  [video] U.S. Stocks Open Higher Despite Unexpected Rise in Jobless Claims at TheStreet
09:15AM  Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy PR Newswire
09:03AM  Wal-Mart's woes; Kohl's climbs; Cisco cuts jobs Hot Stock Minute
08:03AM  [video] Amgen's cancer drug fails to improve survival rates at CNBC
13-Aug-14 06:31PM  [$$] Amgen Cancer Drug Kyprolis Fails Trial at The Wall Street Journal
06:04PM  Much Ado About Nothing? Amgen Drops in After Hours on Failed Trial, Recall at Barrons.com
05:04PM  After hours buzz: Cisco, NetApp, Amgen and more at CNBC
04:55PM  Amgen recalls syringes of anemia drug Aranesp at MarketWatch
04:55PM  Amgen drug fails to improve survival in multiple myeloma trial Reuters
04:53PM  [$$] Amgen Cancer Drug Kyprolis Fails Trial at The Wall Street Journal
04:34PM  CORRECT: Amgen shares fall after-hours on disappointing trial data at MarketWatch
04:32PM  Amgen Drops in After Hours on Failed Trial, Recall at Barrons.com
04:19PM  Amgen shares fall after-hours on disappointing trial data at MarketWatch
04:12PM  Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates PR Newswire
04:01PM  Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis® In Patients With Relapsed And Advanced Refractory Multiple Myeloma PR Newswire
12-Aug-14 01:04PM  AMGEN INC Financials EDGAR Online Financials
11-Aug-14 01:41PM  Amgen rally gets cool reception optionMONSTER
08-Aug-14 10:26AM  Howard Zauberman, the President and CEO of Vision-Sciences, Inc. (VSCI), Interviews with The Wall Street Transcript Wall Street Transcript
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. Its principal products include Neulasta, a pegylated protein for the treatment of chemotherapy-induced febrile neutropenia; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for treating the patients with non-myeloid malignancies; and Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. The company's principal products also comprise Aranesp and EPOGEN erythropoiesis-stimulating agents for the treatment of anemia and dialysis; XGEVA and Prolia for the prevention of skeletal-related events and treatment of postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. Its other marketed products include Nplate, a thrombopoietic compound; and Vectibix, a human monoclonal antibody. The company's products in phase 3 clinical trial comprise Evolocumab, a human monoclonal antibody used for the treatment for dyslipidemia; Talimogene Laherparepvec for the treatment of unresected stage IIIB, IIIC, or IV melanoma; and Trebananib for the treatment of ovarian cancer. Its other product in development stage includes Ivabradine, an oral drug for chronic heart failure and stable angina in patients with elevated heart rates. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and pharmaceutical wholesale distributors. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc.; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COFFMAN VANCE DDirectorSep 05Option Exercise56.7920,0001,135,80041,623Sep 09 06:54 PM
Harper Sean EEVP, Research & DevelopmentAug 05Sale127.2914,0001,782,12659,503Aug 07 04:22 PM
Dittrich Thomas J.W.VP, Finance & CAOMay 21Option Exercise56.644,130233,91122,719May 22 05:15 PM
Dittrich Thomas J.W.VP, Finance & CAOMay 21Sale112.834,130465,98418,589May 22 05:15 PM
Bradway Robert AChairman, CEO and PresidentMay 12Buy111.7789499,919185,013May 12 08:33 PM
Michael A KellyActing CFOApr 28Sale110.452,065228,07241,041Apr 29 05:48 PM
de Carbonnel FrancoisDirectorMar 06Option Exercise54.4410,000544,35025,364Mar 07 05:23 PM
de Carbonnel FrancoisDirectorMar 06Sale126.691,000126,69018,343Mar 07 05:23 PM
BALTIMORE DAVIDDirectorFeb 26Option Exercise62.555,000312,75031,879Feb 26 08:28 PM
HENDERSON REBECCA MDirectorFeb 13Option Exercise62.4120,0001,248,16025,549Feb 14 04:34 PM
HENDERSON REBECCA MDirectorFeb 13Sale123.5320,0002,470,6805,549Feb 14 04:34 PM
Bradway Robert AChairman, CEO and PresidentFeb 12Option Exercise62.5565,0004,065,750216,040Feb 14 04:19 PM
AMGEN INC10% OwnerDec 17Buy7.00272,1421,904,994541,399Dec 18 06:09 PM
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E21.04 EPS (ttm)5.13 Insider Own0.10% Shs Outstand897.43M Perf Week0.42%
Market Cap96.85B Forward P/E17.00 EPS next Y6.35 Insider Trans-7.43% Shs Float894.74M Perf Month6.31%
Income4.70B PEG1.57 EPS next Q1.49 Inst Own81.40% Short Float0.76% Perf Quarter9.12%
Sales22.86B P/S4.24 EPS this Y13.80% Inst Trans-1.11% Short Ratio2.33 Perf Half Y15.02%
Book/sh23.78 P/B4.54 EPS next Y14.31% ROA9.40% Target Price113.07 Perf Year40.72%
Cash/sh1.71 P/C63.01 EPS next 5Y13.37% ROE22.20% 52W Range73.19 - 108.74 Perf YTD30.32%
Dividend2.00 P/FCF63.34 EPS past 5Y15.70% ROI15.50% 52W High-0.75% Beta1.05
Dividend %1.85% Quick Ratio1.00 Sales past 5Y4.10% Gross Margin73.60% 52W Low47.45% ATR1.13
Employees46608 Current Ratio1.20 Sales Q/Q10.00% Oper. Margin34.90% RSI (14)71.97 Volatility1.05% 0.98%
OptionableYes Debt/Eq0.51 EPS Q/Q21.20% Profit Margin20.60% Rel Volume1.24 Prev Close107.04
ShortableYes LT Debt/Eq0.48 EarningsOct 23 BMO Payout30.80% Avg Volume2.90M Price107.92
Recom2.00 SMA201.79% SMA505.54% SMA20015.60% Volume3,591,500 Change0.82%
30-Jun-14Reiterated Barclays Overweight $115 → $105
24-Jun-14Reiterated FBR Capital Mkt Perform $110 → $120
10-Jun-14Upgrade RBC Capital Mkts Sector Perform → Outperform $97 → $115
13-May-14Reiterated Argus Buy $193 → $208
17-Apr-14Reiterated Cowen Outperform $196 → $197
02-Apr-14Reiterated FBR Capital Outperform $200 → $220
17-Mar-14Reiterated Barclays Overweight $195 → $205
31-Jan-14Reiterated Argus Buy $179 → $193
24-Jan-14Reiterated FBR Capital Outperform $195 → $200
13-Jan-14Reiterated FBR Capital Outperform $180 → $195
16-Dec-13Reiterated Deutsche Bank Buy $175 → $198
02-Dec-13Reiterated Barclays Overweight $191 → $195
30-Oct-13Downgrade Robert W. Baird Outperform → Neutral $175 → $173
17-Oct-13Reiterated Cowen Outperform $174 → $170
29-Jul-13Reiterated FBR Capital Outperform $165 → $180
19-Jul-13Reiterated Argus Buy $155 → $179
28-May-13Reiterated BMO Capital Markets Outperform $160 → $171
22-May-13Reiterated Barclays Overweight $160 → $170
19-Apr-13Reiterated RBC Capital Mkts Sector Perform $134 → $148
19-Apr-13Reiterated Barclays Overweight $158 → $160
15-Sep-14 11:46AM  Union Pacific Railroad Urges Professional Photographers to Stay Safe, Stay Away From Train Tracks PR Newswire
12-Sep-14 06:58PM  Cramer: Rate spike, Alibaba and other concerns at CNBC
11-Sep-14 03:00PM  Union Pacific Railroad Police Receive Prominent CALEA Accreditation PR Newswire
10-Sep-14 12:17PM  U.S. Silica Raises Guidance, Expands Output Capacity at Investor's Business Daily
09:00AM  Overview: Ambre Energya coal and oil shale export company Market Realist
08-Sep-14 08:25PM  Top-Yielding Dividend Funds Ahead Of The S&P 500 at Investor's Business Daily
05-Sep-14 01:00PM  Buffetts BNSF Seeks Toehold in Mexico as Rivals Tap Boom at Bloomberg
04-Sep-14 06:16PM  Transportation Stocks Sharing Load Of Market Leadership at Investor's Business Daily
05:28PM  Today's Market Thorns, Roses, and All Time Highs Yahoo Finance Blogs
02:20PM  [video] Rail car stocks to watch at CNBC
01:00PM  Powder River Basin rail connectivity hampers Cloud Peak Energy Market Realist
03-Sep-14 06:28PM  New Managers Revive Thrivent Large Cap Growth Fund at Investor's Business Daily
05:41PM  The Market's Roses, Thorns, and All Time Highs... Yahoo Finance Blogs
02-Sep-14 05:39PM  Today's Thorns, Roses and All Time Highs in the Markets... Yahoo Finance Blogs
01:03PM  3 Stocks Pushing The Services Sector Higher at TheStreet
30-Aug-14 08:02AM  Trinity, GasLog Among 5 Energy Movers In IBD 50 at Investor's Business Daily
28-Aug-14 01:04PM  Oil By Rail Still Expanding Despite Accidents at Investor's Business Daily
27-Aug-14 08:00AM  Union Pacific Corporation CFO Rob Knight to Address Cowen and Company 7th Annual Global Transportation & Aerospace / Defense Conference PR Newswire
21-Aug-14 10:50AM  Union Pacific Scales a 52-Week High on Impressive Q2 Results Zacks
20-Aug-14 08:08PM  Jim Cramer's 'Mad Money' Recap: Where's the Economy Headed? Check the Railroads at TheStreet
07:43PM  Jim Cramer's 'Mad Money' Recap: Where's the Economy Headed? Check the Railroads at TheStreet
07:28PM  Jim Cramer's 'Mad Money' Recap: Where's the Economy Headed? Check the Railroads at TheStreet
06:13PM  Cramer: Economic challenges too great for stocks? at CNBC
05:30PM  The New All-Time Highs... Yahoo Finance Blogs
04:12PM  [video] Vulcan, Union Pacific on Right Track Says Centre Fund Manager at TheStreet
08:28AM  Zacks Industry Outlook Highlights: CSX, Kansas City Southern, Union Pacific, Canadian National Railway and Norfolk Southern Zacks
19-Aug-14 04:05PM  Union Pacific Banks on Strength in Sectors, Economic Growth Zacks
18-Aug-14 06:42PM  Canadian Pacific, Amid Turaround, Outpaces Rail Peers at Investor's Business Daily
03:36PM  [$$] Head-On Train Crash in Arkansas Kills 2 at The Wall Street Journal
01:39PM  Five Reasons to Buy Union Pacific Today at Barrons.com
11:29AM  Credit Suisse's 5 Reasons To Buy Union Pacific Benzinga
09:04AM  Will This Price Target Increase Help Union Pacific (UNP) Stock Today? at TheStreet
08:05AM  RPT-Slow pace of rail recovery stirs fear of future woes Reuters
07:39AM  Top Trade Ideas for the Week of August 18, 2014: Bonus Idea - Union Pacific Yahoo Finance Blogs
06:56AM  2 dead, 2 hurt in Arkansas freight train collision AP
12:59AM  [$$] Head-On Train Crash in Arkansas Kills 2 at The Wall Street Journal
15-Aug-14 07:00AM  RPT-Slow pace of rail recovery stirs fear of future woes Reuters
14-Aug-14 06:36PM  How Top Active Mutual Fund Managers Outperform at Investor's Business Daily
05:04PM  Union Pacific Railroad Achieves Best-Ever First Half Derailment Safety Performance PR Newswire
13-Aug-14 08:25AM  COLUMN-Why railroads are taking a fresh look at natural gas: Kemp Reuters
12-Aug-14 11:18AM  Macquarie Upgrades Union Pacific, Kansas City; Revisits Railroad Sector Benzinga
11:12AM  UNION PACIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07-Aug-14 06:34PM  Berkshire Leads Most Daily Bond Sales in U.S. Since June at Bloomberg
05:39PM  4 Small Cap Stocks That Top Mutual Funds Favor at Investor's Business Daily
04:49PM  Berkshire's Quarterly Report: An Exercise In Obfuscation at Forbes
06-Aug-14 06:40AM  Union Pacific (UNP): Strong Industry, Solid Earnings Estimate Revisions Zacks
01-Aug-14 01:04PM  UNION PACIFIC CORP Financials EDGAR Online Financials
31-Jul-14 11:07PM  This sector could be signaling a correction Talking Numbers
04:30PM  UNION PACIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:59PM  Union Pacific (UNP) Declares 50c Dividend Today at TheStreet
01:59PM  Union Pacific Corporation Announces 10 Percent Dividend Increase for Third Quarter 2014 PR Newswire
29-Jul-14 02:41PM  Note to SelfPay Attention here! Yahoo Finance Blogs
27-Jul-14 02:34AM  Union Pacific Corporation - Steady As She Goes, Buy On Dips at Seeking Alpha
26-Jul-14 11:55AM  The American Economy Keeps Moving With Union Pacific Reporting Good Earnings at Seeking Alpha
25-Jul-14 03:23PM  Buffetts BNSF Losing Freight to Rival as Service Slows at Bloomberg
01:32PM  Frigid Winter Fuels Rail Shipments of Coal at Fox Business
11:59AM  UNION PACIFIC CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
24-Jul-14 05:19PM  Union Pacific 2Q profit chugs ahead 17 percent AP
04:01PM  Union Pacific's (UNP) CEO John Koraleski on Q2 2014 Results - Earnings Call Transcript Seeking Alpha
02:00PM  Norfolk Southern Q2 Earnings Top Estimates on High Revenues Zacks
01:10PM  Buffetts BNSF Losing Freight to Rival as Service Slows at Bloomberg
12:46PM  [video] Union Pacific Bolstered by Economic Growth: CEO at Bloomberg
11:51AM  Union Pacific 2Q profit chugs ahead 17 percent AP
11:04AM  Union Pacific Corporation Delivers Solid Q2 Results; Shares Retreat at Motley Fool
10:35AM  [video] Union Pacific CEO: Everything heading right direction at CNBC
10:33AM  Union Pacific Beats Q2 Earnings and Revenue Estimates Zacks
09:54AM  Union Pacific (UNP) Is Today's Unusual Social Activity Stock at TheStreet
09:21AM  Union Pacific 2Q profit chugs ahead 17 percent AP
08:37AM  Union Pacific profit rises on higher grain, coal shipments Reuters
08:32AM  Union Pacific Profit Meets Estimates as Recovery Spurs Freight at Bloomberg
08:26AM  [$$] Union Pacific Profit Rises at The Wall Street Journal
08:13AM  UNION PACIFIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
08:09AM  Union Pacific profit rises as agricultural shipments increase Reuters
08:04AM  Union Pacific says optimistic about second half of year at theflyonthewall.com
08:00AM  Union Pacific Reports All-Time Quarterly Records PR Newswire
07:07AM  Q2 2014 Union Pacific Earnings Release - Before Market Open CCBN
23-Jul-14 10:09PM  Is Union Pacific Poised To Beat The Whisper Number? at Seeking Alpha
05:12PM  Ryder CEO Sees Brisk Rentals As Recovery Unfolds at Investor's Business Daily
02:53PM  What to Watch in The Day Ahead; Thursday, July 24 Reuters
10:26AM  These Unorthodox Economic Gauges Show the Economy is Chugging Along at Fox Business
09:46AM  New Lifetime High Today: Union Pacific (UNP) at TheStreet
22-Jul-14 07:20AM  4 Railroad Stocks That You Should Consider at Motley Fool
21-Jul-14 09:41AM  Follow Goldman with These Equity ETFs Zacks
18-Jul-14 06:06PM  Is It Too Late To Buy Rail Stocks? Base Count Says No at Investor's Business Daily
01:03PM  Today's Stocks Driving Success For The Transportation Industry at TheStreet
11:42AM  Grains, Autos Push Kansas City Southern Earnings Up at Investor's Business Daily
09:20AM  Canadian Pacific Misses Q2 Earnings, Profits Up on Volume Zacks
17-Jul-14 12:34PM  Canadian Pacific Powers Through To Strong Q2 Earnings at Investor's Business Daily
09:46AM  Genesee & Wyoming: The Weather Is Good Again at Seeking Alpha
09:00AM  Union Pacific Corporation Invites You to Join Its Second Quarter 2014 Earnings Release Broadcast PR Newswire
05:47AM  United Pacific Corporation - An Investment To Look Forward To at Seeking Alpha
16-Jul-14 12:33PM  CSX optimistic long-term but predicts flat 3Q AP
08:13AM  White Mountains Insurance Group, Dick's Sporting Goods, Southwest Airlines, Norfolk Southern and Union Pacific highlighted as Zacks Bull and Bear of the Day Zacks
15-Jul-14 04:22PM  CSX Sales Hit Record as Rail Cargo Shows Economy Strength at Bloomberg
14-Jul-14 01:07PM  Great Railroad Boom of 2014 Can No Longer Be Ignored: StockTwits at TheStreet
08:02AM  CSX Earnings: Will Crude Rail Shipments Trump Coal? at Investor's Business Daily
13-Jul-14 07:50PM  [$$] Railroads' Gravy Train Heads for a Bump at The Wall Street Journal
03:10PM  How to Invest Like Buffett With the Union Pacific Railroad at Motley Fool
10-Jul-14 07:42AM  BNSF And Union Pacific Have Intermodal Advantages at Seeking Alpha
09-Jul-14 06:00PM  Union Pacific Reports Environmental Strategies, Stewardship and Risks to CDP PR Newswire
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, provides rail transportation services in the United States. The company offers freight transportation services for agricultural products, including grains, commodities produced from grains, food, and beverage products; automotive products, such as imported and exported shipments, finished vehicles, and automotive parts; and chemicals consisting of industrial chemicals, plastics, crude oil, liquid petroleum gases, fertilizers, soda ash, sodium products, and phosphorus rock and sulfur products. It also provides transportation services for coal and petroleum coke; industrial products comprising construction products, metals, minerals, consumer goods, lumber, paper, and other miscellaneous products, as well as steel, aggregate, cement, and wood products; and intermodal import and export containers and trailers. Its rail network includes 31,838 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROGEL STEVEN RDirectorSep 08Option Exercise14.7812,200180,31616,200Sep 09 04:14 PM
ROGEL STEVEN RDirectorSep 08Sale107.5312,2001,311,8294,000Sep 09 04:14 PM
HOPE RICHARDS JUDITHDirectorSep 03Option Exercise14.7812,200180,31627,740Sep 05 12:28 PM
HOPE RICHARDS JUDITHDirectorSep 03Sale106.446,200659,92821,540Sep 05 12:28 PM
DUREN DIANE KEVP & CORPORATE SECRETARYAug 29Option Exercise54.6331,3481,712,610145,756Sep 02 01:11 PM
DUREN DIANE KEVP & CORPORATE SECRETARYAug 29Sale105.0431,3483,292,716131,410Sep 02 01:11 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJul 16Sale101.752,021205,63757,493Jul 17 05:49 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJul 16Sale101.753,867393,467109,781Jul 17 05:49 PM
FRITZ LANCE MPRESIDENT & COOJun 11Option Exercise46.8028,1281,316,390224,126Jun 13 04:54 PM
BUTLER ERIC LEVP MKTG & SALESApr 17Sale190.0010,0081,901,52097,562Apr 21 05:34 PM
BUTLER ERIC LEVP MKTG & SALESApr 07Sale186.8020,2733,786,996107,570Apr 08 04:46 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCMar 20Sale186.901,498279,97629,757Mar 21 12:05 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCMar 20Sale187.736,8421,284,42456,824Mar 21 12:05 PM
THAL GAYLA LSVP LAW & GEN COUNSELMar 19Sale189.816,4001,214,78436,828Mar 20 05:55 PM
KNIGHT ROBERT M JREVP FINANCE & CFO UPCMar 18Sale188.008,9051,674,140151,808Mar 18 05:42 PM
KNIGHT ROBERT M JREVP FINANCE & CFO UPCMar 17Sale186.587,5991,417,853160,713Mar 18 05:42 PM
DUREN DIANE KEVP & CORPORATE SECRETARYMar 11Sale186.503,055569,75865,705Mar 13 03:57 PM
KORALESKI JOHN JPRESIDENT & CEOMar 10Option Exercise93.6030,9362,895,610161,915Mar 11 05:32 PM
DAVIS ERROLL B JRDirectorFeb 28Option Exercise48.493,700179,4136,058Mar 03 04:59 PM
DAVIS ERROLL B JRDirectorFeb 28Sale178.813,700661,5882,358Mar 03 04:59 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCFeb 12Sale179.251,166209,00663,666Feb 13 06:23 PM
THAL GAYLA LSVP LAW & GEN COUNSELFeb 10Option Exercise93.601,360127,29644,261Feb 10 05:39 PM
BUTLER ERIC LEVP MKTG & SALESFeb 10Option Exercise62.3816,2421,013,176138,712Feb 10 05:21 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJan 23Sale172.751,028177,58755,360Jan 24 07:19 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCJan 13Option Exercise48.492,458119,18857,977Jan 14 01:37 PM
BUTLER ERIC LEVP MKTG & SALESJan 13Option Exercise60.982,000121,96097,252Jan 14 01:56 PM
TOTUSEK JEFFREY PVP CONTROLLER & CAO UPCDec 26Sale166.251,224203,49055,519Dec 27 10:27 AM
DONOHUE THOMAS JDirectorDec 05Sale163.1414,1622,310,3484,554Dec 06 03:48 PM
THAL GAYLA LSVP LAW & GEN COUNSELNov 22Option Exercise93.602,720254,59241,497Nov 25 05:59 PM
THAL GAYLA LSVP LAW & GEN COUNSELNov 22Sale162.002,720440,64038,777Nov 25 05:59 PM
DAVIS ERROLL B JRDirectorOct 22Option Exercise43.034,200180,7266,547Oct 23 04:31 PM
MCCONNELL MICHAEL WDirectorOct 22Option Exercise32.555,500179,0257,500Oct 24 06:17 PM
MCCONNELL MICHAEL WDirectorOct 22Sale155.131,160179,9456,340Oct 24 06:17 PM
DAVIS ERROLL B JRDirectorOct 22Sale155.364,200652,5182,347Oct 23 04:31 PM
KNIGHT ROBERT M JREVP FINANCE & CFO UPCSep 18Sale160.0010,0001,600,000142,683Sep 20 10:22 AM
BIIB [NASD]
Biogen Idec Inc.
IndexS&P 500 P/E36.32 EPS (ttm)9.00 Insider Own0.10% Shs Outstand236.14M Perf Week0.02%
Market Cap77.19B Forward P/E20.26 EPS next Y16.13 Insider Trans-4.06% Shs Float235.91M Perf Month-4.55%
Income2.14B PEG1.82 EPS next Q3.45 Inst Own92.20% Short Float1.35% Perf Quarter7.25%
Sales8.34B P/S9.25 EPS this Y35.60% Inst Trans-0.42% Short Ratio2.85 Perf Half Y-7.12%
Book/sh40.40 P/B8.09 EPS next Y23.19% ROA17.70% Target Price371.95 Perf Year36.44%
Cash/sh6.66 P/C49.07 EPS next 5Y20.00% ROE24.10% 52W Range221.07 - 358.89 Perf YTD16.92%
Dividend- P/FCF32.72 EPS past 5Y24.10% ROI20.70% 52W High-8.92% Beta1.23
Dividend %- Quick Ratio1.70 Sales past 5Y11.10% Gross Margin87.20% 52W Low47.86% ATR7.35
Employees6850 Current Ratio2.00 Sales Q/Q40.50% Oper. Margin35.80% RSI (14)47.52 Volatility2.52% 1.98%
OptionableYes Debt/Eq0.06 EPS Q/Q46.10% Profit Margin25.60% Rel Volume0.89 Prev Close320.12
ShortableYes LT Debt/Eq0.06 EarningsJul 23 BMO Payout0.00% Avg Volume1.12M Price326.88
Recom2.10 SMA20-2.97% SMA50-0.74% SMA2004.98% Volume991,200 Change2.11%
19-Aug-14Resumed Stifel Buy $376
29-Jul-14Reiterated Argus Buy $360 → $385
24-Jul-14Reiterated UBS Neutral $330 → $354
09-Jul-14Reiterated RBC Capital Mkts Outperform $325 → $375
19-Mar-14Reiterated Stifel Buy $360 → $376
07-Mar-14Reiterated Barclays Overweight $325 → $352
03-Mar-14Reiterated Stifel Buy $330 → $360
30-Jan-14Reiterated UBS Neutral $300 → $310
30-Jan-14Reiterated Brean Capital Buy $293 → $377
30-Jan-14Reiterated Argus Buy $310 → $360
28-Jan-14Reiterated Deutsche Bank Buy $340 → $415
27-Jan-14Reiterated Canaccord Genuity Buy $291 → $355
16-Jan-14Reiterated Stifel Buy $296 → $321
10-Jan-14Reiterated Barclays Overweight $285 → $325
20-Dec-13Reiterated RBC Capital Mkts Outperform $275 → $325
12-Dec-13Reiterated Argus Buy $280 → $310
30-Oct-13Initiated FBR Capital Mkt Perform $259
29-Oct-13Reiterated Barclays Overweight $240 → $262
17-Jul-13Reiterated Barclays Overweight $220 → $240
09-May-13Reiterated MKM Partners Neutral $208 → $215
16-Sep-14 07:41AM  Zacks Rank #1 Additions for Tuesday Zacks
15-Sep-14 04:50PM  Biogen/AbbVie Report Positive Data on MS Drug Zinbryta Zacks
02:55PM  Nasdaq Falls Hard, But Apple Resilient On iPhone Orders at Investor's Business Daily
01:04PM  3 Stocks Underperforming Today In The Drugs Industry at TheStreet
13-Sep-14 08:02AM  Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers at Investor's Business Daily
12-Sep-14 04:30PM  Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada Zacks
03:30PM  Biogen Reports Positive Two-Year Data on MS Drug Plegridy Zacks
07:30AM  Detailed Results from Biogen Idec and AbbVies Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA (Daclizumab High-Yield Process) Business Wire
11-Sep-14 05:41PM  Medivation Eyes Blockbuster As Cancer Drug Gets An OK at Investor's Business Daily
02:46PM  Stocks Show Modest Losses; Biotechs Pressured Again at Investor's Business Daily
09:20AM  Short Sellers Remain Vigilant Against Biotechs at 24/7 Wall St.
08:17AM  Biogen Idec, Inc. Suddenly Struggling To Keep Up With The Biotech Joneses Benzinga
08:17AM  Biogen Idec Inc Suddenly Struggling To Keep Up With The Biotech Joneses Benzinga
07:30AM  PLEGRIDY (Peginterferon Beta-1a) Two-Year Data Confirm Maintenance of Efficacy and Safety in Multiple Sclerosis Patients Business Wire
07:30AM  New Data from ENDORSE Show Positive Results Continued over Five Years with TECFIDERA® (Dimethyl Fumarate) in a Wide Range of Multiple Sclerosis Patients Business Wire
01:00AM  Sanofi aims to grow Genzyme unit with new drugs and acquisitions Reuters
10-Sep-14 01:25PM  Stocks Turn Higher After Soft Start; U.S. Silica Jumps at Investor's Business Daily
11:58AM  ReceptosMS Drug Yields More Good Data; Stock Jumps at Investor's Business Daily
11:58AM  Receptos MS Drug Yields More Good Data; Stock Jumps at Investor's Business Daily
10:17AM  Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Zacks
07:00AM  New International Survey Finds MS Patients and Neurologists View Communication Positively, Yet Struggle to Discuss Key MS Symptoms Business Wire
09-Sep-14 01:04PM  3 Stocks Pushing The Drugs Industry Lower at TheStreet
08-Sep-14 08:48AM  J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig at TheStreet
05-Sep-14 12:54PM  [video] 3 Biotech picks: Gilead, Biogen & Celgene at CNBC
12:04PM  Indexes Trim Losses But Remain Lower At Midday at Investor's Business Daily
04-Sep-14 11:01AM  Celgene: Good Data But What About the Patent Challenges? at Barrons.com
03-Sep-14 08:00AM  Biogen Idec Data at Joint ACTRIMS-ECTRIMS Meeting Highlight Robust Multiple Sclerosis Portfolio and Commitment to Advancing Patient Care Business Wire
02-Sep-14 07:36PM  Biotech Helps Drive Broad Market at Investor's Business Daily
04:01PM  Biogen Idec to Present at the Morgan Stanley Global Healthcare Conference 2014 Business Wire
09:56AM  This tiny biotech company takes the real ice bucket challenge at MarketWatch
09:16AM  This tiny biotech company takes the real ice bucket challenge at MarketWatch
06:10AM  Biotech companies take the real ice bucket challenge at MarketWatch
27-Aug-14 05:20PM  Biogen's Eloctate Approved in Canada for Hemophilia A Zacks
11:04AM  Should you buy ISIS? No, not that one at CNNMoney.com
10:25AM  Rising Short Interest in Biotech Stocks 24/7 Wall St.
26-Aug-14 05:55PM  Celgene, Gilead Lead Big Biotech Stock Movers at Investor's Business Daily
04:01PM  Biogen Idec in Panel at the Citi 9th Annual Biotech Conference Business Wire
02:38PM  Celgene, Gilead Lead Big Biotech Stock Movers at Investor's Business Daily
08:00AM  Health Canada Approves Eloctate, the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A PR Newswire
08:00AM  Health Canada Approves Eloctate, the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A CNW Group
08:00AM  Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub Business Wire
25-Aug-14 02:54PM  Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs at Investor's Business Daily
22-Aug-14 06:37PM  Majority Of IBD 50 Firms Strong On Sponsorship at Investor's Business Daily
04:35PM  Data on Celgene's Revlimid Published in Oncology Journal Zacks
21-Aug-14 03:47PM  5 companies that will benefit from ALS awareness at MarketWatch
03:20PM  Dell CIO Andi Karaboutis Leaving for Biotech Firm Biogen at The Wall Street Journal
07:53AM  The Zacks Analyst Blog Highlights: Achillion Pharmaceuticals, Gilead Sciences, Amgen, Roche and Biogen Zacks
07:00AM  Biogen Idec Names Adriana Karaboutis EVP, Technology and Business Solutions Business Wire
20-Aug-14 02:31PM  What Investors Gain from Large, Mid & Small-Cap Growth Funds Zacks
08:40AM  6 Biotech Stocks to Buy Now With Up to 100% Upside Potential 24/7 Wall St.
19-Aug-14 02:31PM  [video] Hottest stories not always hottest stock: Greenberg at CNBC
12:39PM  Want a better return than Apple or Google? at CNBC
12:20PM  Biogen Strengthens MS Portfolio with Plegridy FDA Approval Zacks
18-Aug-14 11:44AM  Why Biogen Idec (BIIB) Stock Is Gaining Today at TheStreet
11:19AM  Biogen Idec: Drug Approval Offers 'Underappreciated Earnings Upside," Morgan Stanley Says at Barrons.com
09:16AM  [video] Cramer: Market about Russia-Ukraine at CNBC
15-Aug-14 07:27PM  FDA approves Biogen's MS drug Plegridy AP
06:49PM  Biogen wins U.S. approval of long acting multiple sclerosis drug Reuters
06:36PM  FDA approves Biogen Idec's multiple sclerosis drug Reuters
06:32PM  Biogen Idecs PLEGRIDY(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis Business Wire
09:49AM  Today's Momo Momentum Stock Is Biogen Idec (BIIB) at TheStreet
07:36AM  [video] ALS stunned by millions of dollars at CNBC
07:32AM  [video] What is ALS? at CNBC
14-Aug-14 06:36PM  Perrigo Regains Some Lost Ground On Fiscal Q4 Beat at Investor's Business Daily
01:15PM  Perrigo Beats on Q4 Earnings and Sales, Provides Guidance Zacks
12:34PM  Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks at TheStreet
11:02AM  Perrigo Q4 Beats Estimates, But Guidance Misses at Investor's Business Daily
13-Aug-14 06:08PM  Cramer: Is Street preparing for the worst? at CNBC
04:30PM  Stocks close higher for the third time in four days on tech boost at CNBC
02:29PM  Stocks higher on biotech, transports at CNBC
02:07PM  Stocks higher on biotech, transports; Nasdaq up 1% at CNBC
01:21PM  Stocks higher on biotech, transports at CNBC
09:50AM  [video] CNBC ice bucket brigade at CNBC
09:44AM  Biogen...and CNBC take the ice bucket challenge at CNBC
12-Aug-14 07:16PM  Top Large-Cap Growth Fund Owns Biogen, Facebook at Investor's Business Daily
01:25PM  Biogen...and CNBC take the ice bucket challenge at CNBC
01:24PM  [video] Costolo accepts CNBC's ice bucket challenge at CNBC
12:57PM  [video] CNBC's Wapner accepts ice bucket challenge at CNBC
12:35PM  [video] Biogen accepts ice bucket challenge at CNBC
08:54AM  [video] Ice Bucket Challenge for ALS at CNBC
08-Aug-14 10:26AM  Howard Zauberman, the President and CEO of Vision-Sciences, Inc. (VSCI), Interviews with The Wall Street Transcript Wall Street Transcript
07:00AM  #PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq Benzinga
07-Aug-14 08:10AM  Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss Zacks
06-Aug-14 01:23PM  Celgene: Five Reasons to Be Bullish at Barrons.com
05-Aug-14 02:17PM  [video] Enormous hype about Ebola: Doctor at CNBC
01:30PM  [video] Risk & compassionate use drug requests at CNBC
08:00AM  Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis PR Newswire
04-Aug-14 08:20AM  Acorda Beats on Q2 Earnings & Revenues, Maintains View Zacks
01-Aug-14 12:01PM  Wall Street Transcript Interview with Charles R. Kummeth, the President and CEO of Bio-Techne (TECH) Wall Street Transcript
31-Jul-14 09:33AM  Stock Market News for July 31, 2014 Zacks
08:26AM  The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene Zacks
08:10AM  Increased Earnings Estimates Seen for Biogen Idec (BIIB): Can It Move Higher? Zacks
30-Jul-14 06:00PM  [video] Cramer's 5 steps of the stock market at CNBC
01:04PM  BIOGEN IDEC INC. Financials EDGAR Online Financials
11:04AM  Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues Zacks
10:00AM  Biogen Idec (BIIB) Highlighted As Momo Momentum Stock at TheStreet
29-Jul-14 05:47PM  Top Large-Cap Growth Funds Defy Group's Gravity at Investor's Business Daily
08:40AM  Top Analyst Upgrades and Downgrades: AcelRx, Alcoa, Costco, Lululemon, Walmart, Trulia and More at 24/7 Wall St.
06:54AM  [$$] Undervalued Biotech Stocks Beat the Index at Barrons.com
28-Jul-14 07:06PM  Ken Fisher's Top Increaes of the Second Quarter Gurufocus
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. It provides AVONEX to treat relapsing MS; TYSABRI to treat relapsing forms of MS and Crohn's disease; RITUXAN for treating relapsed or refractory, follicular, CD20-positive, and B-cell Non-Hodgkin's lymphoma (NHL); FUMADERM to treat severe plaque psoriasis in adult patients; FAMPYRA, an oral compound for the improvement of walking in adult patients with MS; TECFIDERA for the treatment of MS; and GAZYVA, an injection for intravenous infusion that treats an untreated chronic lymphocytic leukemia. The company's products that completed Phase III clinical trials comprise ELOCTATE and ALPROLIX, an inherited disorder that inhibits blood coagulations; and Peginterferon beta-1a to prolong the effects and reduce the dosing frequency of interferon beta-1a. Its products under Phase III clinical trials consist of Daclizumab, a monoclonal antibody in relapsing MS; TYSABRI for secondary progressive MS; and GA101, a monoclonal antibody for chronic lymphocytic leukemia and NHL. The company's Phase II clinical trial products include Anti-LINGO for optic neuritis; STX-100 for idiopathic pulmonary fibrosis; Neublastin for neuropathic pain; and ANTI-TWAEK for lupus nephritis. Its Phase I clinical trial products comprise BIIB037 for Alzheimer's disease; BIIB037 for MS; and Anti-CD40 Ligand for general lupus, as well as Phase 1b/2a clinical trial products include ISIS-SMNRx for spinal muscular atrophy. Biogen Idec Inc. has collaboration agreements with Genentech, Inc.; Acorda Therapeutics, Inc.; Sangamo BioSciences; and Swedish Orphan Biovitrum AB. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCANGOS GEORGE AChief Executive OfficerSep 02Sale345.471,128389,69020,240Sep 04 04:15 PM
SCANGOS GEORGE AChief Executive OfficerAug 01Sale332.931,128375,54521,368Aug 04 04:43 PM
SCANGOS GEORGE AChief Executive OfficerJul 16Sale312.3712,3163,847,14922,496Jul 18 05:59 PM
SCANGOS GEORGE AChief Executive OfficerJul 15Option Exercise0.0021,339044,874Jul 17 04:45 PM
Posner Brian SDirectorJun 20Sale315.00605190,5756,000Jun 23 04:37 PM
Posner Brian SDirectorJun 13Sale310.50700217,3506,605Jun 16 04:37 PM
SCANGOS GEORGE AChief Executive OfficerJun 02Sale318.93484154,36223,535Jun 03 04:29 PM
Holtzman Steven HEVP Corporate DevelopmentMay 19Sale289.151,221353,0525,749May 20 04:16 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01Option Exercise286.7534799,5021,029May 02 04:20 PM
SCANGOS GEORGE AChief Executive OfficerMay 01Sale285.562,123606,24124,019May 02 04:22 PM
Holtzman Steven HEVP Corporate DevelopmentApr 17Sale291.001,221355,3116,970Apr 21 05:07 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerApr 02Option Exercise0.0097502,677Apr 03 04:27 PM
SCANGOS GEORGE AChief Executive OfficerApr 01Sale308.422,123654,77626,142Apr 02 04:16 PM
Posner Brian SDirectorMar 31Sale296.763,000890,2756,435Apr 01 04:15 PM
DORSA CAROLINEDirectorMar 20Option Exercise53.6410,000536,40024,468Mar 21 04:17 PM
DORSA CAROLINEDirectorMar 20Sale348.8810,0003,488,81314,468Mar 21 04:17 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentMar 19Sale352.293,5051,234,7767,976Mar 21 04:15 PM
Holtzman Steven HEVP Corporate DevelopmentMar 17Sale334.831,221408,8278,191Mar 18 05:08 PM
Kingsley Stuart AEVP, Global Comm. OperationsMar 11Sale336.838,4282,838,7663,511Mar 12 07:15 PM
SCANGOS GEORGE AChief Executive OfficerMar 10Sale333.7726,1248,719,37828,265Mar 12 07:20 PM
LEAMING NANCYDirectorMar 10Sale327.652,000655,3007,660Mar 12 07:16 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 04Sale342.583,1711,086,32115,407Mar 05 03:12 PM
SCANGOS GEORGE AChief Executive OfficerMar 03Sale335.792,942987,89454,389Mar 04 03:19 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 26Sale342.171,048358,59421,407Feb 27 04:19 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 23Option Exercise0.001,988023,395Feb 25 02:21 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23Option Exercise0.002,598026,706Feb 25 02:17 PM
Clancy Paul JExecutive VP and CFOFeb 23Option Exercise0.004,280017,473Feb 25 02:11 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 23Option Exercise0.003,821023,930Feb 25 02:07 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 18Sale327.901,222400,6949,412Feb 19 04:23 PM
DiPietro KennethEVP Human ResourcesFeb 13Sale316.811,290408,6850Feb 14 04:36 PM
SCANGOS GEORGE AChief Executive OfficerFeb 13Sale316.81486153,97057,331Feb 14 04:37 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 13Sale316.42425134,47821,407Feb 14 04:42 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 12Option Exercise0.002,246012,998Feb 14 04:33 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 12Option Exercise0.003,573013,166Feb 14 04:48 PM
Clancy Paul JExecutive VP and CFOFeb 12Option Exercise0.002,807014,517Feb 14 04:46 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 12Option Exercise0.002,142021,119Feb 14 04:43 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12Option Exercise0.0071401,941Feb 14 04:45 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 12Option Exercise0.00792014,459Feb 14 04:42 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 12Option Exercise0.002,142011,644Feb 14 04:39 PM
SCANGOS GEORGE AChief Executive OfficerFeb 12Option Exercise0.009,189062,150Feb 14 04:37 PM
DiPietro KennethEVP Human ResourcesFeb 12Option Exercise0.002,24602,246Feb 14 04:36 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12Option Exercise0.003150690Feb 14 04:38 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12Option Exercise0.002,246025,167Feb 14 04:34 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 11Sale314.312,085655,33613,667Feb 12 05:03 PM
SCANGOS GEORGE AChief Executive OfficerFeb 11Sale314.312,456771,94552,961Feb 12 05:00 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10Option Exercise0.0018,833064,297Feb 11 07:55 PM
Clancy Paul JExecutive VP and CFOFeb 09Option Exercise0.004,691013,922Feb 11 07:49 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09Option Exercise0.0011,270050,314Feb 11 07:55 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09Option Exercise0.001,824011,613Feb 11 07:52 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 09Option Exercise0.003,909020,723Feb 11 06:07 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09Option Exercise0.001,824016,346Feb 11 07:43 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09Option Exercise0.004,691025,133Feb 11 06:07 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08Option Exercise0.004,023021,883Feb 11 06:07 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 08Option Exercise0.001,277014,944Feb 11 07:43 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 08Option Exercise0.002,498017,633Feb 11 06:07 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 08Option Exercise0.002,636011,032Feb 11 07:52 PM
Clancy Paul JExecutive VP and CFOFeb 08Option Exercise0.003,191010,278Feb 11 07:49 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 08Option Exercise0.003,468011,229Feb 11 07:47 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08Option Exercise0.002,705010,778Feb 11 07:45 PM
DiPietro KennethEVP Human ResourcesFeb 04Sale299.011,655494,8620Feb 05 04:36 PM
DiPietro KennethEVP Human ResourcesFeb 01Option Exercise0.002,46302,463Feb 03 05:29 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01Option Exercise0.005,15909,730Feb 03 05:25 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 01Option Exercise0.004,586010,097Feb 03 05:20 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 01Option Exercise0.005,159010,044Feb 03 05:15 PM
Rowinsky Eric KDirectorJan 21Sale310.092,020626,38210,440Jan 22 04:49 PM
YOUNG WILLIAMDirectorJan 08Sale285.1115,0004,276,59018,509Jan 09 04:24 PM
PANGIA ROBERT WDirectorJan 06Option Exercise47.556,250297,18820,253Jan 07 12:22 PM
PANGIA ROBERT WDirectorJan 06Sale278.036,2501,737,68814,003Jan 07 12:22 PM
SHERWIN STEPHEN ADirectorJan 02Option Exercise59.825,500329,0109,460Jan 06 11:19 AM
SHERWIN STEPHEN ADirectorJan 02Sale279.285,5001,536,0593,960Jan 06 11:19 AM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 04Sale285.90439125,51013,667Dec 05 02:53 PM
SCHENK LYNNDirectorDec 02Sale291.711,000291,7104,100Dec 02 03:28 PM
Pawlicki RaymondSVP, Chief Information OfficerNov 22Option Exercise49.954,000199,80012,710Nov 25 02:11 PM
Pawlicki RaymondSVP, Chief Information OfficerNov 22Sale288.004,0001,152,0008,710Nov 25 02:11 PM
SCHENK LYNNDirectorNov 01Sale245.001,000245,0005,100Nov 05 12:18 PM
SCANGOS GEORGE AChief Executive OfficerNov 01Sale245.572,239549,83139,044Nov 05 12:13 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerOct 22Option Exercise60.5615,030910,21729,530Oct 23 05:03 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerOct 22Sale250.1115,0303,759,12314,500Oct 23 05:03 PM
SCHENK LYNNDirectorOct 01Sale242.851,000242,8506,100Oct 02 05:09 PM
SCANGOS GEORGE AChief Executive OfficerOct 01Sale242.852,239543,74141,283Oct 02 04:35 PM
DiPietro KennethEVP Human ResourcesSep 30Sale242.001,440348,4800Oct 02 01:36 PM
Clancy Paul JExecutive VP and CFOSep 18Option Exercise49.6526,7851,329,87533,872Sep 19 02:14 PM
Clancy Paul JExecutive VP and CFOSep 18Sale245.0026,7856,562,3257,087Sep 19 02:14 PM
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E15.85 EPS (ttm)5.50 Insider Own0.50% Shs Outstand971.62M Perf Week-1.16%
Market Cap84.69B Forward P/E14.31 EPS next Y6.09 Insider Trans1.50% Shs Float956.45M Perf Month7.43%
Income5.50B PEG1.69 EPS next Q1.53 Inst Own91.50% Short Float2.38% Perf Quarter11.97%
Sales126.02B P/S0.67 EPS this Y4.20% Inst Trans-0.91% Short Ratio6.20 Perf Half Y12.74%
Book/sh33.64 P/B2.59 EPS next Y9.14% ROA6.60% Target Price92.19 Perf Year17.94%
Cash/sh8.53 P/C10.22 EPS next 5Y9.36% ROE17.00% 52W Range65.63 - 88.50 Perf YTD17.21%
Dividend1.50 P/FCF19.75 EPS past 5Y18.00% ROI13.00% 52W High-1.51% Beta0.55
Dividend %1.72% Quick Ratio0.70 Sales past 5Y8.60% Gross Margin- 52W Low32.80% ATR1.27
Employees156000 Current Ratio0.70 Sales Q/Q7.10% Oper. Margin7.70% RSI (14)60.13 Volatility1.54% 1.42%
OptionableYes Debt/Eq0.51 EPS Q/Q1.40% Profit Margin4.40% Rel Volume0.80 Prev Close86.03
ShortableYes LT Debt/Eq0.44 EarningsOct 15 BMO Payout21.90% Avg Volume3.67M Price87.16
Recom2.00 SMA201.90% SMA504.10% SMA20012.08% Volume2,973,700 Change1.31%
18-Jul-14Reiterated Oppenheimer Outperform $84 → $94
18-Jul-14Reiterated Deutsche Bank Buy $92 → $95
18-Jul-14Reiterated Barclays Overweight $84 → $99
17-Jul-14Reiterated FBR Capital Outperform $85 → $95
21-Apr-14Reiterated Deutsche Bank Buy $90 → $85
21-Apr-14Reiterated CRT Capital Buy $80 → $90
12-Mar-14Reiterated UBS Buy $84 → $91
21-Jan-14Downgrade Monness Crespi & Hardt Neutral → Sell $59
16-Jan-14Reiterated FBR Capital Outperform $77 → $85
07-Jan-14Upgrade Deutsche Bank Hold → Buy $74 → $85
25-Nov-13Reiterated UBS Buy $81 → $84
13-Nov-13Initiated FBR Capital Outperform
05-Nov-13Downgrade Monness Crespi & Hardt Buy → Neutral
16-Oct-13Reiterated Deutsche Bank Hold $71 → $78
08-Oct-13Reiterated Deutsche Bank Hold $68 → $71
19-Jul-13Reiterated Oppenheimer Outperform $66 → $78
18-Jul-13Reiterated Cantor Fitzgerald Buy $70 → $75
16-Jul-13Reiterated Monness Crespi & Hardt Buy $68 → $75
17-Jun-13Downgrade Standpoint Research Buy → Hold
05-Apr-13Initiated UBS Buy $72
16-Sep-14 03:20PM  Aetna Poised for Organic & Inorganic Growth, Risks Remain Zacks
08:30AM  Study: People Using myHealthcare Cost Estimator Are More Likely to Select High-Quality Physicians Business Wire
15-Sep-14 01:16PM  UnitedHealthcare Wins Two Stevies at the 2014 American Business Awards Business Wire
10:00AM  Dow Jones (DJIA) Today: UnitedHealth Group (UNH) Leads The Day Higher, Caterpillar (CAT) Lags at TheStreet
08:00AM  UnitedHealth Group Named to Dow Jones Sustainability North America and World Indices for 16th Consecutive Year Business Wire
12-Sep-14 04:07PM  Stocks close down ahead of Fed meeting; energy hit at CNBC
03:14PM  Stocks fall, on pace for first losing week in six; Fed eyed at CNBC
03:07PM  All S&P sectors drop; Dow falls at CNBC
02:06PM  All S&P sectors drop; Dow hit by Exxon at CNBC
09:43AM  Retrophin, Gilead, And Our Healthcare Values at Forbes
06:00AM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
11-Sep-14 04:00PM  Georgia and New York Health Departments Receive America's Health Rankings Champion Award from ASTHO and United Health Foundation Business Wire
10-Sep-14 04:30PM  Dow Jones (DJIA) Today: Visa (V) Leads The Day Higher, UnitedHealth Group (UNH) Lags at TheStreet
03:00PM  Aetna Forms ACO in New York with Weill Cornell Physicians Zacks
09-Sep-14 05:46PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
11:08AM  ObamaCare, Government Giveaways, Inefficiencies and Abuse Top $850 Billion Yahoo Finance Blogs
11:00AM  Dow Component UnitedHealth Group (UNH) To Go Ex-dividend Tomorrow at TheStreet
08:00AM  Four New Partner Organizations Join Optum Labs Research Collaborative Business Wire
08-Sep-14 08:00AM  Third Annual National Medicare Education Week Offers Help Before Open Enrollment Period Business Wire
05-Sep-14 04:09PM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
02:35PM  Insurance broker AmeriLife taps Evercore for sale -sources Reuters
09:10AM  UnitedHealth (UNH) Hits 52-Week High on Expansion Plans Zacks
04-Sep-14 06:12PM  Hackers break into server for Obamacare website -U.S. officials Reuters
05:28PM  Today's Market Thorns, Roses, and All Time Highs Yahoo Finance Blogs
04:12PM  US stocks end lower; caution before jobs report at CNBC
03:29PM  US stocks decline ahead of monthly jobs report at CNBC
03:13PM  US stocks decline ahead of monthly jobs report at CNBC
02:39PM  S&P 500 wobbles after run to another record high at CNBC
01:14PM  Dow, S&P 500 topple records after US data, ECB moves at CNBC
11:11AM  Dow, S&P 500 topple records after US data, ECB moves at CNBC
10:20AM  Dow, S&P 500 topple records after US data, ECB moves at CNBC
10:00AM  Dow Today: UnitedHealth Group (UNH) Leads The Day Higher, Verizon Communications (VZ) Lags at TheStreet
08:30AM  Injured Veterans to Cycle 355 Miles from Waltham, Mass., to New York City for 2014 UnitedHealthcare Ride 2 Recovery Minuteman Challenge Business Wire
03-Sep-14 05:41PM  The Market's Roses, Thorns, and All Time Highs... Yahoo Finance Blogs
01-Sep-14 10:51AM  Five Ways ACA And Employers Shift Costs This Open Enrollment Season at Forbes
30-Aug-14 07:30AM  3 ways insurers discourage sick from enrolling at USA TODAY
29-Aug-14 04:26PM  US stocks rise; best August in 14 years for S&P 500 at CNBC
03:40PM  Stocks up, S&P 500 in line for best August since 2000 at CNBC
02:39PM  Stocks mostly up, on track for fourth weekly gain at CNBC
12:58PM  Stocks rise, on track for fourth weekly gain at CNBC
12:58PM  Stocks mostly up, on track for fourth weekly gain at CNBC
28-Aug-14 06:05PM  Another GOP Holdout State Expands Medicaid Under Obamacare at Forbes
05:09PM  Nebraska 4-H and UnitedHealthcare Expand Eat4-Health Partnership, Use Pedal Power to Help Tackle Obesity and Encourage Healthy Lifestyles Among Youth Business Wire
05:50AM  All the Companies Making Money From Healthcare.gov in One Chart at BusinessWeek
27-Aug-14 04:42PM  [video] Apple Edges Higher on New Product Line-up, Markets Close Flat at TheStreet
04:11PM  Stocks little moved as S&P 500 ends above 2,000 again at CNBC
04:04PM  Stocks little moved as S&P 500 ends above 2,000 again at CNBC
03:15PM  US stocks fluctuate; S&P 500 near milestone at CNBC
12:00PM  Dow Today: UnitedHealth Group (UNH) Higher at TheStreet
09:30AM  Arizona Diamondbacks and UnitedHealthcare Reach Their "Pack The House" Goal to Fight Childhood Hunger Business Wire
12:01AM  Insurers pay more tax on executive comp under Obamacare -study Reuters
26-Aug-14 04:10PM  Stocks rise; S&P 500 scores first finish above 2,000 at CNBC
01:03PM  3 Health Services Stocks Moving The Industry Upward at TheStreet
12:46PM  Midday movers: Ann, Best Buy Co., Exxon & more at CNBC
11:46AM  The 10 most influential people in health care at MarketWatch
25-Aug-14 02:02PM  [$$] Corporate Watch: News Digest at The Wall Street Journal
11:00AM  Los Angeles Dodgers, UnitedHealthcare Beautify School Playgrounds, Encourage Children to Get Physically Active Business Wire
24-Aug-14 10:08AM  Hospice Oversight May Come From Rare Bipartisan Health Bill at Forbes
22-Aug-14 01:08PM  Will UnitedHealth Group (UNH) Stock Benefit From Plan Expansion Into More States? at TheStreet
01:08PM  UnitedHealth to expand Obamacare reach from 4 to 24 states for 2015 at MarketWatch
10:14AM  [$$] UnitedHealth to Expand Health-Exchange Policies to 24 States at The Wall Street Journal
21-Aug-14 02:13PM  New York 4-H and UnitedHealthcare Expand Eat4-Health Partnership, Use Pedal Power to Help Tackle Obesity and Encourage Healthy Lifestyles Among Youth Business Wire
01:03PM  3 Stocks Improving Performance Of The Health Services Industry at TheStreet
05:30AM  Wear This Device So the Boss Knows Youre Losing Weight Bloomberg
05:30AM  Wear This Device So the Boss Knows Youre Losing Weight at Bloomberg
20-Aug-14 04:23PM  S&P 500 ends near record high after Fed-rate talk at CNBC
03:17PM  S&P 500 flirts with record close after Fed release at CNBC
02:40PM  Stocks mostly rise as market takes rate talk in stride at CNBC
02:17PM  Stocks turn mostly lower amid rate-hike talk by Fed at CNBC
01:31PM  S&P 500 close to record high before Fed release at CNBC
12:58PM  Stocks gain before Fed minutes; Apple rises to record at CNBC
11:53AM  Stocks gain before Fed minutes; Apple rises to record at CNBC
11:16AM  US stocks edge mostly higher ahead of FOMC minutes at CNBC
10:41AM  US stock indexes mixed ahead of FOMC minutes at CNBC
09:54AM  Stocks turn little changed; Target cuts outlook at CNBC
16-Aug-14 06:06PM  Seattle Area Kids Test Their IRONMAN Skills at UnitedHealthcare IRONKIDS Fun Run Business Wire
15-Aug-14 03:37PM  Population Health Expert: Health Reform As Simple As Changing Incentives at Forbes
13-Aug-14 04:30PM  Stocks close higher for the third time in four days on tech boost at CNBC
04:17PM  Stocks close higher for the third time in four days on biotech boost at CNBC
02:29PM  Stocks higher on biotech, transports at CNBC
02:03PM  Stocks higher on biotech, transports; Nasdaq up 1% at CNBC
01:21PM  Stocks higher on biotech, transports at CNBC
12:44PM  WellPoint: What's in a Name? at Barrons.com
11:40AM  UnitedHealth Group (UNH) Declares Quarterly Dividend at TheStreet
10:01AM  New twists ahead for your employer's health plan at CNBC
07:00AM  UnitedHealth Group Board Authorizes Payment of Quarterly Dividend to Shareholders Business Wire
10-Aug-14 09:30AM  Pro Cyclists Mara Abbott and Cari Higgins Join UnitedHealthcare Employees to Fill USO Care Packages for Troops at Pro Challenge Experience Business Wire
09-Aug-14 01:04PM  UNITEDHEALTH GROUP INC Financials EDGAR Online Financials
08-Aug-14 05:13PM  UnitedHealth Group Acts to Support People in Hawaii Affected by Tropical Storm Iselle, Hurricane Julio Business Wire
01:02PM  Peter G. Jacoby to Lead UnitedHealth Group Government Affairs Business Wire
08:19AM  What I Learned About Health Care When My Cat Died at Forbes
07-Aug-14 07:06PM  Aetna and UnitedHealth Investor's Business Daily
05:49PM  Thorns in the Market today... Yahoo Finance Blogs
04:51PM  [video] U.S. Markets End Lower on Ukraine Conflict Concerns at TheStreet
04:05PM  UnitedHealth drops after Goldman loses conviction at MarketWatch
12:07PM  [video] Trader blitz: Fox flying higher at CNBC
11:00AM  UnitedHealthcare Teams Up with IRONKIDS to Energize Washington Youth During Fun Run in Seattle Business Wire
09:00AM  Centura Health, Colorado Health Neighborhoods and UnitedHealthcare Collaborate to Improve Patient Care Management in Colorado Business Wire
06-Aug-14 08:30AM  Medical Grants Available for Children Business Wire
05-Aug-14 10:10AM  5 Affordable Care Act Stock Winners to Buy Now at 24/7 Wall St.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services; services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 820,000 physicians and other health care professionals, and approximately 6,000 hospitals and other facilities. Its OptumHealth segment provides health management services, integrated care delivery services, consumer engagement and relationship management, sales distribution platform services, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment offers software and information products, advisory consulting services, and business process outsourcing services to hospitals, physicians, commercial health plans, government agencies, life sciences companies, and other organizations. Its OptumRx segment provides pharmacy benefit management services and programs, including retail pharmacy network management; mail order and specialty pharmacy; manufacturer rebate contracting and administration; and benefit plan design and consultation; and claims processing services, as well as offers various formulary management and compliance, drug utilization review, and disease and drug therapy management services. The company was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEATHERDALE DOUGLAS WDirectorSep 16Sale87.164,800418,3488,000Sep 16 04:53 PM
LEATHERDALE DOUGLAS WDirectorSep 16Sale87.2411,000959,648947,809Sep 16 04:53 PM
BURKE RICHARD TDirectorSep 10Option Exercise40.0321,040842,3302,262,689Sep 11 04:28 PM
WILENSKY GAIL RDirectorAug 26Option Exercise43.3910,400451,23661,379Aug 27 04:21 PM
WILENSKY GAIL RDirectorAug 26Sale85.0010,400884,00050,979Aug 27 04:21 PM
LEATHERDALE DOUGLAS WDirectorAug 22Option Exercise50.2643,7602,199,322958,809Aug 25 05:30 PM
BURKE RICHARD TDirectorJun 13Option Exercise30.9311,300349,5022,240,076Jun 16 04:45 PM
BALLARD WILLIAM C JRDirectorMay 09Option Exercise36.8810,000368,80075,556May 12 04:56 PM
BALLARD WILLIAM C JRDirectorMay 09Sale76.8210,000768,18665,556May 12 04:56 PM
LAWSON RODGER ADirectorApr 24Buy76.211,00076,21021,877Apr 25 04:15 PM
Shine Kenneth IrwinDirectorMar 18Option Exercise25.161,25031,45025,335Mar 19 05:39 PM
BALLARD WILLIAM C JRDirectorMar 18Option Exercise30.9010,000309,00075,042Mar 19 05:38 PM
BALLARD WILLIAM C JRDirectorMar 18Sale77.8710,000778,74965,042Mar 19 05:38 PM
Shine Kenneth IrwinDirectorMar 18Sale77.921,25097,40024,085Mar 19 05:39 PM
BURKE RICHARD TDirectorMar 12Option Exercise32.2611,720378,0672,228,262Mar 13 04:55 PM
BOUDREAUX GAILEVP & CEO, UnitedHealthcareFeb 28Sale76.133,678280,006182,532Mar 03 05:05 PM
BOUDREAUX GAILEVP & CEO, UnitedHealthcareFeb 27Option Exercise33.0019,006627,198199,642Mar 03 05:05 PM
BOUDREAUX GAILEVP & CEO, UnitedHealthcareFeb 27Sale76.0486,7146,593,733180,636Mar 03 05:05 PM
RENFRO LARRY CEVP, UHG and CEO, OptumFeb 25Option Exercise31.21168,8245,268,664270,981Feb 27 06:11 PM
RENFRO LARRY CEVP, UHG and CEO, OptumFeb 25Sale75.34131,5699,912,369178,181Feb 27 06:11 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 20Sale73.6925018,42318,970Feb 21 04:30 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 19Option Exercise36.6222,316817,12657,357Feb 21 04:30 PM
RANGEN ERIC SSr VP & Chief Acctg OfficerFeb 19Sale73.5924,5751,808,58019,220Feb 21 04:30 PM
WILENSKY GAIL RDirectorFeb 18Option Exercise33.9421,100716,08571,032Feb 19 04:43 PM
WILENSKY GAIL RDirectorFeb 18Sale74.0321,1001,561,98449,932Feb 19 04:43 PM
BALLARD WILLIAM C JRDirectorJan 21Option Exercise32.4910,000324,85075,042Jan 23 06:16 PM
BALLARD WILLIAM C JRDirectorJan 21Sale73.0510,000730,47665,042Jan 23 06:16 PM
LEATHERDALE DOUGLAS WDirectorDec 05Option Exercise32.4146,2401,498,415959,693Dec 06 05:52 PM
LEATHERDALE DOUGLAS WDirectorDec 05Sale72.8946,2403,370,480913,453Dec 06 05:52 PM
HEMSLEY STEPHEN JPresident & Chief Exec OfficerDec 02Option Exercise58.36600,00035,016,0003,223,895Dec 03 05:18 PM
BURKE RICHARD TDirectorDec 02Option Exercise29.5811,400337,2632,237,478Dec 03 05:18 PM
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E27.52 EPS (ttm)1.46 Insider Own37.38% Shs Outstand1.88B Perf Week-2.26%
Market Cap75.46B Forward P/E24.28 EPS next Y1.66 Insider Trans0.00% Shs Float1.19B Perf Month108.73%
Income2.72B PEG3.37 EPS next Q0.38 Inst Own29.90% Short Float1.00% Perf Quarter116.84%
Sales50.63B P/S1.49 EPS this Y4.40% Inst Trans0.53% Short Ratio3.09 Perf Half Y138.17%
Book/sh8.51 P/B4.72 EPS next Y6.23% ROA6.70% Target Price42.24 Perf Year187.41%
Cash/sh0.13 P/C311.80 EPS next 5Y8.17% ROE18.00% 52W Range13.84 - 41.38 Perf YTD149.72%
Dividend2.88 P/FCF- EPS past 5Y26.20% ROI10.50% 52W High-2.90% Beta0.71
Dividend %7.17% Quick Ratio0.70 Sales past 5Y6.10% Gross Margin7.20% 52W Low190.22% ATR1.15
Employees- Current Ratio0.90 Sales Q/Q12.30% Oper. Margin6.70% RSI (14)79.84 Volatility2.55% 1.64%
OptionableYes Debt/Eq1.18 EPS Q/Q13.30% Profit Margin5.40% Rel Volume0.45 Prev Close39.58
ShortableYes LT Debt/Eq1.10 EarningsJul 31 BMO Payout185.30% Avg Volume3.84M Price40.18
Recom1.70 SMA208.11% SMA5052.70% SMA200108.11% Volume1,734,600 Change1.52%
03-Jun-14Initiated Global Hunter Securities Buy $83
02-May-14Reiterated Stifel Buy $75 → $78
02-May-14Reiterated RBC Capital Mkts Outperform $71 → $80
02-May-14Reiterated Oppenheimer Outperform $74 → $86
20-Mar-14Reiterated Stifel Buy $70 → $75
31-Jan-14Reiterated Argus Buy $70 → $75
06-Jan-14Reiterated Deutsche Bank Buy $70 → $74
02-Aug-13Resumed Oppenheimer Outperform $67 → $71
02-Aug-13Reiterated Stifel Buy $64 → $68
19-Apr-13Reiterated Wunderlich Buy $61 → $66
18-Apr-13Reiterated Deutsche Bank Buy $68 → $70
15-Apr-13Reiterated Deutsche Bank Buy $65 → $68
11-Jan-13Reiterated Deutsche Bank Buy $60 → $62
03-May-12Reiterated UBS Buy $55 → $57
17-Apr-12Initiated Global Hunter Securities Accumulate $53
16-Feb-12Upgrade Argus Hold → Buy $61
11-Jan-12Reiterated Wunderlich Buy $48 → $54
03-Nov-11Reiterated Barclays Capital Overweight $47 → $49
11-May-11Reiterated RBC Capital Mkts Outperform $48 → $50
26-Jan-11Reiterated Ladenburg Thalmann Buy $46.50 → $48
16-Sep-14 06:00AM  'Mad Money' Lightning Round: Buy, Buy, Buy St Jude Medical at TheStreet
15-Sep-14 05:00PM  Must-know: Comparing Enterprise Products Partners to its peers Market Realist
01:04PM  TRP, EPD And SDRL, 3 Basic Materials Stocks Pushing The Sector Lower at TheStreet
01:00PM  Potential concerns for Enterprise Product Partners investors Market Realist
09:45AM  Why Plains All American Pipeline is investing in the Permian Market Realist
09:00AM  Must-know: Enterprise Products Partners growth rate Market Realist
12-Sep-14 05:00PM  Must-know: Enterprise Products Partners distributions Market Realist
01:00PM  US shale boom will drive Enterprise Products Partners exports Market Realist
09:00AM  Why exports will impact Enterprise Products Partners future Market Realist
11-Sep-14 05:01PM  Why crude prices matter for companies like Enterprise Products Market Realist
01:00PM  Why Enterprise Products Partners can continue to outperform Market Realist
09:01AM  Deeper analysis of Enterprise Products Partners 2Q14 performance Market Realist
10-Sep-14 05:43PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05:01PM  Enterprise Products Partners 2Q14 performance by segment Market Realist
01:00PM  A key overview of Enterprise Products Partners 2Q14 results Market Realist
11:00AM  Enterprise Products Hits 52-week High on Proposed Pipeline Zacks
10:01AM  GasLog, Other Oil And Gas Transport Stocks Rebound at Investor's Business Daily
09:00AM  Overview: Enterprise Products Partners refined products businesses Market Realist
09-Sep-14 09:34PM  Deeper analysis of Enterprise Products Partners 2Q14 performance Market Realist
05:00PM  Enterprise Products Partners offshore pipeline businesses Market Realist
01:00PM  Analyzing Enterprise Products Partners crude throughput volumes Market Realist
09:00AM  A guide to Enterprise Products Partners NGL segment performance Market Realist
08-Sep-14 05:55PM  Seasonality and the shale boom affect Enterprise Products Partners Market Realist
01:55PM  Enterprise Products Partners business segments and assets Market Realist
09:55AM  Deeper analysis of Enterprise Products Partners 2Q14 performance Market Realist
09:54AM  An investors introduction to Enterprise Products Partners Market Realist
09:29AM  Enterprise Products to Start Open Season for New Pipeline Zacks
05-Sep-14 08:24AM  Chemical Factory Boom at Risk as U.S. Ethane Heads Abroad at Bloomberg
04-Sep-14 05:49PM  Enterprise to Hold Open Season for Proposed Bakken-to-Cushing Crude Oil Pipeline Business Wire
03-Sep-14 01:05PM  Pioneer sees benefit from improved condensate sales pricing Reuters
12:27PM  Pioneer in talks to sell condensate overseas Reuters
08:30AM  Enterprise Products Partners to Participate in Barclays CEO EnergyPower Conference Business Wire
01-Sep-14 05:00PM  Must-know: Key concerns for Williams Companies in 2014 Market Realist
26-Aug-14 01:08PM  [video] President Obama: Tax inversions bad for American people at CNBC
01:03PM  [video] The energy play at CNBC
06:00AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, EDGAR Online
25-Aug-14 03:50PM  Estate Planning: A Ranking of Good Assets and Bad Assets at Forbes
22-Aug-14 07:03AM  Splits Calendar: Enterprise Products splits before market open today (2:1 ratio) Briefing.com
20-Aug-14 05:40PM  Enterprise Products Partners Growth Projects Look Promising Zacks
19-Aug-14 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials EDGAR Online Financials
08:00AM  Enterprise Products Partners to Participate in Citi MLP Investor Conference Business Wire
14-Aug-14 09:00AM  Consolidation must-know: A look into Kinder Morgans origins Market Realist
12-Aug-14 01:00PM  Must-know: Valeros recent market performance Market Realist
06:00AM  Jim Cramer's Top Stock Picks: KMI BWP PCLN EPD at TheStreet
05:58AM  Dicker: Richard Kinder Does It Again at TheStreet
11-Aug-14 05:15PM  Kinders Pipeline Empire Outgrows the Tax Break He Popularized Bloomberg
05:14PM  Kinder's Shares Gain $1.55 Billion on Consolidation Deal Bloomberg
04:15PM  Enterprise Products Partners to Participate in Goldman Sachs Power, Utilities, MLP and Pipeline Conference Business Wire
10:24AM  Billionaire Kinder Streamlines Empire to Target Rivals Bloomberg
09:03AM  Billionaire Kinder Streamlines Empire to Target Rivals Bloomberg
08:51AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-Q, Quarterly Report EDGAR Online
04:25AM  Billionaire Kinder Streamlines Empire to Target Rivals Bloomberg
08-Aug-14 04:25PM  Buckeye Partners Misses Q2 Earnings Estimates, Revenues Jump Zacks
07-Aug-14 08:20AM  Plains All American Beats on Q2 Earnings, Loses on Y/Y Fall Zacks
06-Aug-14 10:00AM  ONEOK Partners Misses Q2 Earnings Estimates as Expenses Mount Zacks
05-Aug-14 12:58PM  Pioneer says owned most of condensate exported by Enterprise Reuters
11:35AM  Pioneer says 400,000 barrel of condensate exported last week by Enterprise Reuters
04-Aug-14 05:01PM  Pioneer says first cargo of condensate exported end of July Reuters
04:09PM  Walk A Mile In Your Customer's Diapers: Co-Creating The Customer Experience at Forbes
12:30PM  Enterprise Misses Q2 Earnings & Revenue Estimates, Up Y/Y Zacks
01-Aug-14 11:52AM  Key to Oil Export Breakthrough: 'Old-Fashioned Thinking Out of the Box' at The Wall Street Journal
06:33AM  Bakken Rail Bet on a Feeling Pays Off for Globals Slifka at Bloomberg
31-Jul-14 01:07PM  Enterprise Rejects Anything That Moves Growth Promises at Bloomberg
12:49PM  US oil shipment navigates around decades-old ban at CNBC
11:15AM  [video] Oil Shipment Cracks Decades-Old Ban at MarketWatch
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today CCBN
09:08AM  Enterprise looks to expand Houston ethane export terminal Reuters
08:30AM  Enterprise Executes Additional Agreement for Ethane Export Terminal; Evaluating Expansion Options Business Wire
07:39AM  [$$] Enterprise Products Partners Profit, Volumes Rise at The Wall Street Journal
07:34AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today CCBN
07:07AM  Q2 2014 Enterprise Products Partners L.P. Earnings Release - Before Market Open CCBN
06:04AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Fin EDGAR Online
06:00AM  Enterprise Reports Results for Second Quarter 2014 Business Wire
12:32AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today CCBN
30-Jul-14 04:30PM  Enterprise and Genesis Complete Crude Oil Pipeline in the Deepwater Gulf of Mexico Business Wire
28-Jul-14 02:24PM  Can the U.S. Double Its Crude Exports in a Year? at BusinessWeek
10:01AM  Q2 Earnings Preview: Enterprise Products Partners at Motley Fool
27-Jul-14 05:00PM  As U.S. kicks off crude exports, Iran casts a shadow in Asia Reuters
26-Jul-14 01:22PM  Why Lifting the Oil Export Ban Won't Kill Cheap Gas at TheStreet
06:00AM  [video] Why Obama and Congress Won't Lift Oil Export Ban at TheStreet
24-Jul-14 01:00PM  Key risks and extraordinary returns for American refiner stocks Market Realist
12:12PM  [video]Cramer/Dicker: Refiners Are a Huge Stock No-No Right Now at TheStreet
12:19AM  U.S. sells first condensate to Asia in at least 40 years - sources Reuters
23-Jul-14 09:00AM  Why midstream and oilfield service companies need fracking Market Realist
22-Jul-14 02:24PM  Enterprise Product Partners Is Poised To Deliver Long-Term Value at Seeking Alpha
11:49AM  3 Examples of When to Be Patient With MLPs at Motley Fool
21-Jul-14 07:14AM  Don't Be Seduced By Tax Benefits And High Yield -- Beware The MLPs at Forbes
07:14AM  Don't Be Seduced by Tax Benefits and High Yield -- Beware the MLPs at Forbes
19-Jul-14 02:10PM  Oil Insiders Warn: A "Day of Reckoning" Is Upon Us at Motley Fool
16-Jul-14 12:10PM  Plains may build condensate-only pipelines in Texas Permian Basin Reuters
05:52AM  U.S. firm sells condensate to Mitsubishi in 2nd deal to Asia Reuters
15-Jul-14 07:10PM  Ship booked for first condensate export cargo - sources Reuters
04:22PM  Is It Time to Cash Out of Enterprise Products Partners? at Motley Fool
02:43PM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:07AM  [$$] Enterprise Products Unveils Two-for-One Split at The Wall Street Journal
08:23AM  Enterprise Announces Two-for-One Split of Common Units Business Wire
06:32AM  Wall Street Breakfast: Fed Monetary Policy, Microsoft Job Cuts, Condensate Exports at Seeking Alpha
12:24AM  Can Enterprise Products Partners Keep Its Distribution Streak Alive? at Motley Fool
12:01AM  More U.S. Condensate Producers Seen Seeking to Export at Bloomberg
14-Jul-14 02:46PM  Can Enterprise Products Partners Save Your Retirement? at Motley Fool
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally. Its NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as import and export terminal services. This segment operates NGL pipelines aggregating approximately 19,400 miles; NGL and related product storage facilities; and 15 NGL fractionators. The company's Onshore Natural Gas Pipelines & Services segment operates approximately 19,600 miles of onshore natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. This segment also leases salt dome natural gas storage facilities; and markets natural gas. Its Onshore Crude Oil Pipelines & Services segment operates approximately 4,600 miles of onshore crude oil pipelines; and markets crude oil. This segment's pipelines gather and transport crude oil primarily in New Mexico, Oklahoma, and Texas to refineries, centralized storage terminals, and connecting pipelines. The company's Offshore Pipelines & Services segment operates approximately 2,300 miles of offshore natural gas and crude oil pipelines and 6 offshore hub platforms in the northern Gulf of Mexico offshore Texas, Louisiana, Mississippi, and Alabama. Its Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 680 miles of pipelines; butane isomerization complex and related pipeline assets; and octane enhancement and high purity isobutylene production facilities, as well as refined products pipelines of 4,200 miles, as well as offers related marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hildebrandt Stephanie CSVP, General Counsel & SecFeb 10Option Exercise23.9722,500539,250146,533Feb 12 04:17 PM
Hurlburt Terrance LGroup Senior Vice PresidentFeb 04Option Exercise23.4960,0001,409,400240,583Feb 05 05:11 PM
FOWLER W RANDALLEVP & Chief Financial OfficerFeb 03Option Exercise23.59112,5002,653,350447,769Feb 05 05:23 PM
CUNNINGHAM RALPH SDirectorFeb 03Option Exercise23.49120,0002,818,800205,500Feb 05 05:21 PM
ORDEMANN WILLIAMGroup Senior Vice PresidentFeb 03Option Exercise23.69105,0002,487,900511,884Feb 05 05:19 PM
KNESEK MICHAEL JSVP, PAO, & ControllerFeb 03Option Exercise23.4960,0001,409,400323,202Feb 05 05:17 PM
CREEL MICHAEL AChief Executive OfficerFeb 03Option Exercise23.62165,0003,897,300905,268Feb 05 05:15 PM
TEAGUE AJChief Operating OfficerFeb 03Option Exercise23.49120,0002,818,800776,409Feb 05 05:14 PM
BACHMANN RICHARD HDirectorFeb 03Option Exercise23.49120,0002,818,800760,308Feb 05 05:12 PM
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E38.95 EPS (ttm)4.37 Insider Own0.10% Shs Outstand297.18M Perf Week2.46%
Market Cap50.58B Forward P/E20.67 EPS next Y8.23 Insider Trans5.32% Shs Float296.61M Perf Month7.54%
Income1.32B PEG2.29 EPS next Q1.47 Inst Own93.70% Short Float1.35% Perf Quarter6.06%
Sales6.75B P/S7.49 EPS this Y17.60% Inst Trans2.24% Short Ratio2.03 Perf Half Y29.79%
Book/sh22.80 P/B7.46 EPS next Y41.99% ROA11.90% Target Price200.60 Perf Year90.94%
Cash/sh12.50 P/C13.61 EPS next 5Y17.00% ROE19.50% 52W Range87.77 - 174.49 Perf YTD53.37%
Dividend0.20 P/FCF35.38 EPS past 5Y17.90% ROI15.70% 52W High-2.46% Beta0.75
Dividend %0.12% Quick Ratio3.80 Sales past 5Y7.40% Gross Margin87.80% 52W Low93.91% ATR3.27
Employees11700 Current Ratio4.10 Sales Q/Q16.70% Oper. Margin30.60% RSI (14)62.69 Volatility1.56% 1.94%
OptionableYes Debt/Eq0.32 EPS Q/Q17.10% Profit Margin18.70% Rel Volume1.02 Prev Close168.56
ShortableYes LT Debt/Eq0.31 EarningsJul 21 BMO Payout4.60% Avg Volume1.97M Price170.20
Recom1.80 SMA203.23% SMA503.53% SMA20020.28% Volume2,037,800 Change0.97%
22-Jul-14Upgrade UBS Neutral → Buy $180 → $200
28-Apr-14Downgrade Stifel Buy → Hold
22-Apr-14Downgrade Argus Buy → Hold
07-Mar-14Reiterated Barclays Equal Weight $95 → $130
07-Feb-14Reiterated Argus Buy $110 → $130
08-Jan-14Reiterated Argus Buy $110 → $125
07-Jan-14Initiated RBC Capital Mkts Outperform $131
20-Dec-13Reiterated UBS Buy $100 → $116
20-Dec-13Reiterated BMO Capital Markets Outperform $112 → $117
31-Oct-13Reiterated Argus Buy $118 → $110
25-Jun-13Reiterated Canaccord Genuity Hold $111 → $98
24-Jun-13Downgrade Deutsche Bank Buy → Hold
02-May-13Reiterated RBC Capital Mkts Outperform $123 → $119
06-Feb-13Reiterated Stifel Nicolaus Buy $110 → $118
06-Feb-13Reiterated Canaccord Genuity Hold $102 → $111
22-Jan-13Reiterated Canaccord Genuity Hold $101 → $102
19-Sep-12Initiated Canaccord Genuity Hold $101
30-Mar-12Reiterated RBC Capital Mkts Outperform $93 → $106
29-Mar-12Reiterated UBS Buy $100 → $107
29-Mar-12Reiterated Stifel Nicolaus Buy $90 → $110
16-Sep-14 06:53PM  Valeant, Allergan settle suit Investor's Business Daily
05:10PM  Roche Starts Trials on Lampalizumab for Geographic Atrophy Zacks
04:20PM  AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug Zacks
03:12PM  Allergan reaches truce with suitors on special shareholder meeting Reuters
01:09PM  Why It's Time for Allergan Shareholders to Take Some Profits at TheStreet
12:46PM  This is what Allergan's move to allow meeting on Valeant takeover means at MarketWatch
11:57AM  Allergan, Pershing Square Settle: Now What? at Barrons.com
11:36AM  Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
11:36AM  Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
09:42AM  Faber Report: Allergan special meeting CNBC
08:34AM  Tigers Chopra Stumbles in Rise to Top Robertson Empire Bloomberg
07:18AM  Allergan agrees to move forward with meeting AP
06:35AM  Allergan agrees to move forward with meeting AP
03:26AM  Allergan reaches truce with suitors on special shareholder meeting Reuters
01:39AM  Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of Chancery Business Wire
12:57AM  Botox Maker Allergan Agrees to Hold Meeting That Could Lead to Takeover at New York Times
12:57AM  Allergan Agrees to Hold Meeting That Could Lead to Takeover at New York Times
12:51AM  Allergan in Agreement on Dec. 18 Meeting at Bloomberg
12:28AM  Allergan, suitors agree to hold special shareholder meeting on Dec. 18 Reuters
12:14AM  [$$] Pershing Square and Allergan Reach Settlement on Litigation Over Special Meeting Date at The Wall Street Journal
15-Sep-14 11:36PM  Allergan to Hold Special Meeting of Stockholders on Originally Scheduled Date of December 18 without Restriction Business Wire
11:30PM  [$$] Pershing Square and Allergan Near Settlement on Litigation Over Special Meeting Date at The Wall Street Journal
08:03PM  Tigers Chopra Stumbles in Rise to Top Robertson Empire at Bloomberg
05:45PM  Big year for Ackman CNBC
04:35PM  Novartis Presents Positive Data on Lucentis and Jetrea Zacks
12:48PM  Ackman goes to Amsterdam CNBC
12:48PM  [video] Ackman goes to Amsterdam at CNBC
12:22PM  Ackman's New Fund Could Spur More Market Activism at Investor's Business Daily
11:55AM  Pershing Square Submits Additional Special Meeting Requests Business Wire
11:21AM  Judge to decide if Ackman can vote shares in Allergan takeover battle at MarketWatch
04:24AM  Ackmans Pershing Fund Seeks to Raise $2 Billion in IPO at Bloomberg
12:00AM  Latisse Appeal, Scottish Web: Intellectual Property at Bloomberg
12-Sep-14 05:10PM  Judge to decide if Ackman can vote shares in Allergan takeover battle at MarketWatch
04:25PM  Will Allergan's Board Be Revamped to Aid Valeant Buyout? Zacks
12:20PM  Midday movers: eBay, Sprint, Yahoo & more at CNBC
10:05AM  UPDATE 4-Allergan investors owning 35 pct to demand special meeting Reuters
09:20AM  [$$] Pershing Touts More Support for Allergan Special Meeting at The Wall Street Journal
08:40AM  [$$] Pershing Touts More Support for Allergan Special Meeting at The Wall Street Journal
08:00AM  Pershing Square Submits Additional Special Meeting Requests Representing 35% of Allergan Shares Business Wire
11-Sep-14 10:38PM  Allergan investors owning 35 pct to demand special meeting Reuters
08:46PM  Allergan Comments On Pershing Square's Delivery Of Additional Requests From Stockholders Owning 1.5% Of Allergan's Shares Benzinga
08:30PM  Allergan Comments on Pershing Square's Delivery of Additional Requests from Stockholders Owning 1.5% of Allergans Shares Business Wire
05:45PM  Eli Lilly/Boehringer's Insulin Biosimilar Gains EU Approval Zacks
02:14PM  Allergan investors owning 35 pct to demand special meeting -sources Reuters
11:28AM  Allergan investors owning 35 pct to demand special meeting -sources Reuters
11:05AM  Allergan vs. Valeant: Where's Perry Mason When You Need Him? at Barrons.com
10:32AM  Allergan investors owning 35 pct to demand special meeting -sources Reuters
10:03AM  Allergan investors owning 35 pct to demand special meeting-sources Reuters
09:38AM  [video] Faber Report: Valeant submits consents at CNBC
10-Sep-14 03:35PM  Auxilium Pharmaceuticals to Restructure, Cut Jobs by 30% Zacks
11:56AM  Bill Ackman Rips Allergan, Inc. In Letter Benzinga
07:40AM  Early movers: AAPL, TWTR, FDO, DG, MSFT, LE & more at CNBC
09-Sep-14 04:56PM  Ackman urges Allergan board to 'wake up' on Valeant talks Reuters
04:30PM  Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status Zacks
03:48PM  In Letter to Botox Maker, Ackman Attacks Board Inaction on Merger Talks at New York Times
03:09PM  Allergan likely to lose bid to stop takeover by Valeant, analyst says at Los Angeles Times
08-Sep-14 04:35PM  Prana Biotechnology Up on Orphan Drug Status for PBT2 Zacks
04:05PM  Novartis (NVS) Presents Positive Data on Ultibro Breezhaler Zacks
03:45PM  Bayer/Regeneron Looking for Eylea Label Expansion in Japan Zacks
06:30AM  Why Valeant's Hostile Takeover Bid of Allergan Is Bad for Shareholders at TheStreet
05-Sep-14 03:16PM  Stocks Rise, Turn Positive Going Into Final Hour at Investor's Business Daily
10:37AM  Allergan OKs Special Shareholder Meeting Consents at TheStreet
10:20AM  Merck's Anti-PD-1 Drug Keytruda First to be Launched in US Zacks
04-Sep-14 07:28PM  [$$] Allergan Approves Special-Meeting Requests at The Wall Street Journal
07:10PM  Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting of Stockholders Business Wire
04:10PM  Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? Zacks
01:00PM  Paulson & Co. opens a new key position in Hillshire Brands Market Realist
12:45PM  Midday movers: Allergan, BP, Tesla Motors & more at CNBC
09:41AM  [video] Faber Report: Allergan special meeting coming at CNBC
09:33AM  10 Stocks Billionaire John Paulson Loves in 2014 at TheStreet
03-Sep-14 05:56PM  Paulson & Co. starts a new position in DIRECTV in Q2 2014 Market Realist
05:40PM  Sanofi Reports Positive Phase III Data on Dengue Vaccine Zacks
01:56PM  John Paulson & Co. add a significant new position in Allergan Market Realist
09:56AM  Highlights of Paulson & Co.s important positions in 2Q14 Market Realist
02-Sep-14 02:40PM  Glaxo Up on Accelerated Ebola Vaccine Development Process Zacks
01:33PM  U.S. court revives Botox-linked shareholder suit against Allergan Reuters
12:06PM  U.S. court revives shareholder lawsuit vs. Allergan over Botox Reuters
09:01AM  Allergan Files Answer in Federal Court Responding to Valeant and Pershing Squares Counterclaims Business Wire
08:00AM  Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Now Approved in the European Union for the Treatment of Diabetic Macular Edema Business Wire
28-Aug-14 03:40PM  Allergan Seeks Court Order to Stop Valeant, Affiliates Zacks
06:53AM  [video] Legal Victory for Ackman and Valeant Pharma at Bloomberg
12:00AM  Allergan Attempts to Elude Ackman Bid Fuel Bearish Bets at Bloomberg
27-Aug-14 02:52PM  Valeant, Ackman get Oct. 6 trial over Allergan special meeting Reuters
02:48PM  Allergan sets date for special shareholder meeting AP
02:19PM  Valeant, Ackman get October 6 trial over Allergan special meeting Reuters
02:13PM  Valeant, Ackman get Oct. 6 trial over Allergan special meeting Reuters
01:22PM  Allergan v Valeant: When Will It End? at Barrons.com
12:35PM  Valeant, Ackman Win Bid to Fast-Track Allergan Case at Bloomberg
12:15PM  Valeant, Ackman get October 6 trial over Allergan special meeting Reuters
12:08PM  Valeant, Ackman get Oct. 6 trial over Allergan special meeting Reuters
11:45AM  Delaware judge fast-tracks Valeant, Pershing lawsuit over Allergan special meeting Reuters
11:01AM  Allergan seeks injunction to keep Ackman from voting on Valeant deal at MarketWatch
08:02AM  Gilead, Jazz Among 4 Top Big Cap Medicals To Watch at Investor's Business Daily
26-Aug-14 08:57PM  Facing shareholder demands, Allergan calls special meeting for December 18 Reuters
08:55PM  Facing shareholder demands, Allergan calls special meeting for Dec. 18 Reuters
07:53PM  Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws Business Wire
06:45PM  Allergan sets shareholder meeting on hostile takeover attempt at Los Angeles Times
05:47PM  Botox Maker Allergan Sets Date for Special Shareholder Meeting at New York Times
05:39PM  Allergan Says Valeant Seeking Hearing on Shareholder Meeting at Bloomberg
05:17PM  Allergan, facing shareholder demands, calls special meeting for December 18 Reuters
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherman Scott DExecutive Vice President, HRApr 22Option Exercise75.5810,000755,80018,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 22Sale163.0010,0001,630,0008,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Option Exercise73.044,500328,68012,723Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Sale139.854,500629,3258,223Apr 23 07:25 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise36.1533,0001,192,95033,827Dec 20 07:41 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise0.0033,000033,827Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Dec 20 07:41 PM
HUDSON DAWN EDirectorNov 27Sale97.463,000292,38215,800Dec 02 04:52 PM
Jones Trevor MDirectorOct 15Option Exercise51.721,00051,7159,142Oct 16 04:54 PM
Jones Trevor MDirectorOct 15Sale90.142,000180,2807,142Oct 16 04:54 PM
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E17.72 EPS (ttm)6.16 Insider Own0.30% Shs Outstand309.52M Perf Week0.36%
Market Cap33.79B Forward P/E14.85 EPS next Y7.35 Insider Trans-3.33% Shs Float308.26M Perf Month4.48%
Income1.92B PEG1.60 EPS next Q1.77 Inst Own66.50% Short Float1.38% Perf Quarter7.56%
Sales11.44B P/S2.95 EPS this Y12.50% Inst Trans-0.94% Short Ratio3.03 Perf Half Y13.59%
Book/sh39.02 P/B2.80 EPS next Y13.32% ROA5.90% Target Price115.15 Perf Year45.35%
Cash/sh5.39 P/C20.27 EPS next 5Y11.08% ROE16.90% 52W Range74.59 - 109.70 Perf YTD18.97%
Dividend2.28 P/FCF74.10 EPS past 5Y6.00% ROI10.60% 52W High-0.48% Beta1.15
Dividend %2.09% Quick Ratio1.30 Sales past 5Y1.10% Gross Margin38.10% 52W Low46.37% ATR1.30
Employees30103 Current Ratio1.40 Sales Q/Q8.60% Oper. Margin29.90% RSI (14)61.83 Volatility1.23% 1.13%
OptionableYes Debt/Eq0.77 EPS Q/Q24.00% Profit Margin16.80% Rel Volume1.11 Prev Close108.17
ShortableYes LT Debt/Eq0.73 EarningsOct 22 BMO Payout34.20% Avg Volume1.40M Price109.17
Recom2.30 SMA201.85% SMA503.86% SMA20012.59% Volume1,550,500 Change0.92%
24-Jul-14Reiterated RBC Capital Mkts Sector Perform $111 → $114
30-Jun-14Upgrade Barclays Equal Weight → Overweight $110 → $112
24-Jun-14Reiterated FBR Capital Outperform $115 → $125
23-Jan-14Reiterated RBC Capital Mkts Sector Perform $91 → $100
23-Jan-14Reiterated Deutsche Bank Hold $91 → $96
23-Jan-14Reiterated Cowen Outperform $98 → $110
23-Jan-14Reiterated Barclays Equal Weight $93 → $101
16-Jan-14Downgrade Stifel Buy → Hold
13-Jan-14Reiterated FBR Capital Outperform $100 → $115
16-Dec-13Reiterated Deutsche Bank Hold $83 → $91
24-Oct-13Reiterated Deutsche Bank Hold $80 → $83
24-Oct-13Reiterated Barclays Equal Weight $85 → $93
17-Oct-13Downgrade RBC Capital Mkts Outperform → Sector Perform $94 → $89
28-May-13Reiterated BMO Capital Markets Outperform $82 → $91
24-Apr-13Reiterated UBS Neutral $76 → $78
24-Apr-13Reiterated Deutsche Bank Buy $84 → $85
24-Apr-13Reiterated Barclays Equal Weight $75 → $78
12-Apr-13Upgrade FBR Capital Mkt Perform → Outperform
10-Apr-13Reiterated Deutsche Bank Buy $78 → $84
08-Apr-13Reiterated BMO Capital Markets Outperform $80 → $82
16-Sep-14 07:46PM  Final Glance: Railroad companies AP
01:22PM  Midday Glance: Railroad companies AP
10:43AM  Early Glance: Railroad companies AP
15-Sep-14 06:03PM  Final Glance: Railroad companies AP
04:58PM  Norfolk Southern announces webcast information for 2014 Investor and Financial Analyst Conference PR Newswire
10:37AM  Early Glance: Railroad companies AP
12-Sep-14 06:02PM  Final Glance: Railroad companies AP
02:37PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
01:20PM  Midday Glance: Railroad companies AP
11:13AM  Early Glance: Railroad companies AP
11-Sep-14 06:02PM  Final Glance: Railroad companies AP
02:09PM  Midday Glance: Railroad companies AP
10:29AM  Early Glance: Railroad companies AP
10-Sep-14 06:16PM  Final Glance: Railroad companies AP
09-Sep-14 04:02PM  Consolidated Rail Corporation -- Moody's upgrades Consolidated Rail's senior unsecured rating to Baa1; outlook stable at Moody's
08-Sep-14 05:08PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05-Sep-14 06:13PM  Today's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05:30PM  [$$] Norfolk Southern CEO Sells $13.2M in Stock at Barrons.com
12:15PM  What Drove Norfolk Southern (NSC) to a 52-Week High? Zacks
02-Sep-14 04:01PM  Norfolk Southern Announces 2014 Investor and Financial Analyst Conference PR Newswire
28-Aug-14 05:03PM  Fed Chair Yellen's assets up 8% during 2013 at USA TODAY
25-Aug-14 05:28PM  Norfolk Southern Banks on Intermodal, Merchandise Strength Zacks
20-Aug-14 08:28AM  Zacks Industry Outlook Highlights: CSX, Kansas City Southern, Union Pacific, Canadian National Railway and Norfolk Southern Zacks
18-Aug-14 06:42PM  Canadian Pacific, Amid Turaround, Outpaces Rail Peers at Investor's Business Daily
08:05AM  RPT-Slow pace of rail recovery stirs fear of future woes Reuters
15-Aug-14 07:00AM  RPT-Slow pace of rail recovery stirs fear of future woes Reuters
12-Aug-14 11:18AM  Macquarie Upgrades Union Pacific, Kansas City; Revisits Railroad Sector Benzinga
11-Aug-14 02:37PM  Norfolk Southern CEO Moorman to address Cowen and Company 7th Annual Global Transportation & Aerospace/Defense Conference PR Newswire
08-Aug-14 08:00AM  Norfolk Southern reports progress and efforts to reduce environmental impact PR Newswire
07-Aug-14 10:28AM  Norfolk Southern brings 40 emergency responders from nine states to world-class training center for crude-by-rail safety class PR Newswire
08:52AM  Yahoo Finance Contributors Digest 08/07/14: Morning Edition Yahoo Finance Blogs
31-Jul-14 09:43AM  Norfolk Southern named to 'green' supply chain list PR Newswire
30-Jul-14 01:04PM  NORFOLK SOUTHERN CORP Financials EDGAR Online Financials
29-Jul-14 03:01PM  Poor employee training blamed for 2012 New Jersey Conrail derailment Reuters
28-Jul-14 07:13PM  Not in my backyard: US sending dirty coal abroad AP
07:12PM  Not in my backyard: US sending dirty coal abroad AP
03:31PM  Not in my backyard: US sending dirty coal abroad AP
02:23AM  Not in my backyard: US sending dirty coal abroad AP
12:05AM  Not in my backyard: US sending dirty coal abroad AP
25-Jul-14 01:32PM  Frigid Winter Fuels Rail Shipments of Coal at Fox Business
08:10AM  Norfolk Southern Is Performing on All Fronts, But Wait for a Pullback at Wall St. Cheat Sheet
24-Jul-14 03:51PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial EDGAR Online
02:00PM  Norfolk Southern Q2 Earnings Top Estimates on High Revenues Zacks
10:35AM  [video] Union Pacific CEO: Everything heading right direction at CNBC
23-Jul-14 03:55PM  Why Norfolk Southern (NSC) Stock Is Declining Today at TheStreet
03:37PM  Norfolk Southern sees economy growing at 'reasonable' pace into 2015 at theflyonthewall.com
03:35PM  [video] Norfolk Southern CEO: Rail industry 'great safety record' at CNBC
01:52PM  [video] DOT readies new rail rules at CNBC
01:03PM  3 Stocks Dragging The Transportation Industry Downward at TheStreet
09:31AM  Norfolk CEO: Much slower crude trains would disrupt US rail business Reuters
09:06AM  Norfolk Southern posts better-than-expected profit Reuters
08:45AM  Norfolk Southern Corp Earnings Call scheduled for 8:45 am ET today CCBN
08:32AM  [$$] Norfolk Southern Profit Rises at The Wall Street Journal
08:13AM  Norfolk Southern posts higher profit as volumes rise Reuters
08:06AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08:00AM  Norfolk Southern reports record second-quarter 2014 results PR Newswire
07:07AM  Q2 2014 Norfolk Southern Corp Earnings Release - 08:00 am ET CCBN
22-Jul-14 06:20PM  Will Norfolk Southern (NSC) Beat Earnings This Season? Zacks
02:20PM  Norfolk Southern raises quarterly dividend 6% to 57c from 54c per share theflyonthewall.com
02:19PM  Norfolk Southern raises quarterly dividend PR Newswire
09:46AM  Norfolk Southern (NSC) Reaches New Lifetime High Today at TheStreet
06:53AM  Why Earnings Season Could Be Great for Norfolk Southern (NSC) Zacks
18-Jul-14 06:30PM  Politics fade as earnings take over at CNBC
06:06PM  Is It Too Late To Buy Rail Stocks? Base Count Says No at Investor's Business Daily
17-Jul-14 10:23PM  Norfolk Southern Corporation -- Moody's withdraws Norfolk Southern's P-2 short-term rating at Moody's
09:46AM  Genesee & Wyoming: The Weather Is Good Again at Seeking Alpha
16-Jul-14 10:45AM  Norfolk Southern's corporate sustainability efforts benefit customers, shareholders, consumers, and communities PR Newswire
08:13AM  White Mountains Insurance Group, Dick's Sporting Goods, Southwest Airlines, Norfolk Southern and Union Pacific highlighted as Zacks Bull and Bear of the Day Zacks
15-Jul-14 04:22PM  CSX Sales Hit Record as Rail Cargo Shows Economy Strength at Bloomberg
14-Jul-14 08:02AM  CSX Earnings: Will Crude Rail Shipments Trump Coal? at Investor's Business Daily
11-Jul-14 01:02PM  3 Stocks Driving The Services Sector Higher at TheStreet
12:47AM  Corrections & Amplifications at The Wall Street Journal
12:18AM  Corrections & Amplifications at The Wall Street Journal
10-Jul-14 10:56PM  Corrections & Amplifications at The Wall Street Journal
07:42AM  BNSF And Union Pacific Have Intermodal Advantages at Seeking Alpha
07-Jul-14 10:55AM  Q. and A. With Stuart Elliott at New York Times
10:55AM  Q. and A. With Stuart Elliott at New York Times
30-Jun-14 03:54PM  Norfolk Southern upgraded by Barclays Briefing.com
02:38PM  Norfolk Southern to host second-quarter 2014 earnings conference call PR Newswire
12:13PM  Midday movers: Allergan, MBIA, Treehouse Foods & More at CNBC
10:58AM  [video] Bullis Calls on FedEx and Norfolk Southern at Jefferies at TheStreet
09:58AM  Why Norfolk Southern (NSC) Stock Is Gaining Today at TheStreet
27-Jun-14 12:46PM  [$$] Norfolk Southern Withdraws Tank-Car Legal-Protection Rule at The Wall Street Journal
12:46PM  [$$] Norfolk Southern Withdraws Tank-Car Legal-Protection Rule
26-Jun-14 10:01PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars at The Wall Street Journal
10:01PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars
08:46PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars
07:57PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars
07:47PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars
06:45PM  [$$] Norfolk Southern to Require Legal Protection Against Older Tank Cars
20-Jun-14 04:05PM  Norfolk Southern-Operation Lifesaver safety train promotes public safety in Delaware and Pennsylvania PR Newswire
04:05PM  Norfolk Southern-Operation Lifesaver safety train promotes public safety in Delaware and Pennsylvania
19-Jun-14 05:00PM  Why Chilton starts new position in Wyndham Worldwide Market Realist
16-Jun-14 02:15PM  Updated Research Report on Norfolk Southern Zacks
02:15PM  Updated Research Report on Norfolk Southern
15-Jun-14 12:46PM  Norfolk Southern Corp. vs. CSX Corporation: Which Stock's Dividend Dominates? at Motley Fool
12:46PM  Norfolk Southern Corp. vs. CSX Corporation: Which Stock's Dividend Dominates?
10-Jun-14 01:02PM  3 Stocks Pushing The Transportation Industry Lower at TheStreet
01:02PM  3 Stocks Pushing The Transportation Industry Lower
12:04PM  Union Pacific Is Seen Gaining Steam On Volume, Mexico at Investor's Business Daily
Norfolk Southern Corporation, together with its subsidiaries, is engaged in the rail transportation of raw materials, intermediate products, and finished goods. As of December 31, 2013, it operated approximately 20,000 miles of road in 22 states and the District of Columbia. The company also operates scheduled passenger trains; transports overseas freight through various Atlantic and Gulf Coast ports; and provides logistics services. In addition, it provides bimodal truckload transportation services primarily utilizing RoadRailer trailers, a hybrid technology that facilitates over-the-road and on-the-rail transportation in the eastern United States, as well as in Ontario and Quebec through a network of terminals. Further, the company is engaged in the acquisition, leasing, and management of coal, oil, gas, and minerals; development of commercial real estate; telecommunications; and leasing or sale of rail property and equipment. The company is founded in 1883 and is based Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Squires James APresidentSep 04Option Exercise50.143,987199,910103,811Sep 08 04:46 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 03Option Exercise50.7412,030610,402152,662Sep 04 03:28 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 03Sale107.9512,0301,298,639140,632Sep 04 03:28 PM
MOORMAN CHARLES WChairman & CEOSep 02Option Exercise49.5677,4793,839,472394,390Sep 03 04:26 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 02Option Exercise50.7410,000507,400150,632Sep 04 03:28 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsSep 02Sale107.6510,0001,076,548140,632Sep 04 03:28 PM
MOORMAN CHARLES WChairman & CEOSep 02Sale107.0077,4798,290,431316,911Sep 03 04:26 PM
MOORMAN CHARLES WChairman & CEOAug 29Option Exercise49.5645,5042,254,951362,415Sep 03 04:26 PM
MOORMAN CHARLES WChairman & CEOAug 29Sale107.0045,5044,868,928316,911Sep 03 04:26 PM
Squires James APresidentJul 29Option Exercise50.7432,0301,625,202131,854Jul 30 03:40 PM
Squires James APresidentJul 29Sale104.9532,0303,361,54999,824Jul 30 03:40 PM
Butler Deborah HExec. V.P.- Planning & CIOJul 25Option Exercise50.7434,0001,725,16083,995Jul 29 03:57 PM
Butler Deborah HExec. V.P.- Planning & CIOJul 25Sale107.3732,9603,538,83651,035Jul 29 03:57 PM
Earhart Cynthia CExec. VP - AdministrationJul 24Option Exercise49.432,077102,6562,077Jul 28 03:07 PM
Hurlbut Thomas EVice President and ControllerJul 24Option Exercise50.127,477374,75317,909Jul 28 05:01 PM
Hurlbut Thomas EVice President and ControllerJul 24Sale107.797,449802,95210,460Jul 28 05:01 PM
Earhart Cynthia CExec. VP - AdministrationJul 24Sale107.782,077223,8510Jul 28 03:07 PM
Manion Mark DExec. Vice President & COOJun 06Option Exercise50.7432,0301,625,20260,542Jun 09 03:46 PM
Manion Mark DExec. Vice President & COOJun 06Sale101.5532,0303,252,72728,512Jun 09 03:46 PM
Butler Deborah HExec. V.P.- Planning & CIOJun 04Sale99.151,00099,15347,752Jun 05 01:55 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsMay 29Option Exercise43.914,553199,933145,482May 30 03:17 PM
Butler Deborah HExec. V.P.- Planning & CIOMay 13Sale97.635,000488,17448,752May 14 03:12 PM
Hurlbut Thomas EVice President and ControllerMay 09Sale95.251,200114,30010,432May 13 03:49 PM
SEALE DONALD WExec. V.P. and CMOMay 01Option Exercise50.143,987199,910194,857May 02 02:03 PM
STEWART MARTA REVP-Finance and CFOApr 29Option Exercise49.432,02399,98734,313May 01 02:03 PM
Squires James APresidentApr 24Option Exercise49.432,02399,98799,824Apr 28 08:32 AM
MOORMAN CHARLES WChairman & CEOMar 13Option Exercise49.906,010299,897324,800Mar 17 04:39 PM
Hurlbut Thomas EVice President and ControllerMar 12Option Exercise49.432,02399,98712,755Mar 14 02:55 PM
Manion Mark DExec. Vice President & COOFeb 12Option Exercise49.5631,9831,584,91876,668Feb 13 12:10 PM
Manion Mark DExec. Vice President & COOFeb 12Sale93.4747,4014,430,57129,267Feb 13 12:10 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsFeb 07Option Exercise49.5621,9831,089,368177,540Feb 10 02:33 PM
Earhart Cynthia CExec. VP - AdministrationFeb 07Option Exercise34.103,300112,53049,545Feb 11 12:15 PM
Earhart Cynthia CExec. VP - AdministrationFeb 07Sale93.6236834,45249,177Feb 11 12:15 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsFeb 07Sale94.0521,9832,067,501155,557Feb 10 02:33 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsFeb 06Option Exercise49.562,01799,952155,557Feb 10 02:33 PM
Manion Mark DExec. Vice President & COOFeb 06Sale93.5314,1401,322,51444,685Feb 07 11:53 AM
Butler Deborah HExec. V.P.- Planning & CIOJan 30Option Exercise38.7110,000387,05062,214Jan 31 07:00 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsJan 30Option Exercise49.5610,000495,550163,540Feb 03 02:59 PM
Butler Deborah HExec. V.P.- Planning & CIOJan 30Sale92.0010,000920,00052,214Jan 31 07:00 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsJan 30Sale92.5010,000925,000153,540Feb 03 02:59 PM
Butler Deborah HExec. V.P.- Planning & CIOJan 29Option Exercise0.0010,000056,984Jan 31 07:00 PM
Earhart Cynthia CExec. VP - AdministrationJan 29Option Exercise0.002,000046,907Jan 31 07:00 PM
Hurlbut Thomas EVice President and ControllerJan 29Option Exercise0.001,000011,064Jan 31 07:00 PM
MOORMAN CHARLES WChairman & CEOJan 29Option Exercise0.0035,5000335,724Jan 31 07:00 PM
Manion Mark DExec. Vice President & COOJan 29Option Exercise0.0010,000068,671Jan 31 07:00 PM
SEALE DONALD WExec. V.P. and CMOJan 29Option Exercise0.0010,0000162,714Jan 31 07:00 PM
Squires James APresidentJan 29Option Exercise0.0010,0000102,571Jan 31 07:00 PM
STEWART MARTA REVP-Finance and CFOJan 29Option Exercise0.002,000032,952Jan 31 07:00 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsJan 29Option Exercise0.0010,0000158,310Jan 31 07:00 PM
MOORMAN CHARLES WChairman & CEOJan 28Option Exercise49.4372,9773,606,888373,201Jan 30 02:52 PM
MOORMAN CHARLES WChairman & CEOJan 28Sale91.4272,9776,671,236300,224Jan 30 02:52 PM
Manion Mark DExec. Vice President & COOJan 27Option Exercise49.4422,0171,088,45278,864Jan 29 05:08 PM
Manion Mark DExec. Vice President & COOJan 27Sale90.8617,9771,633,47858,671Jan 29 05:08 PM
STEWART MARTA REVP-Finance and CFODec 20Option Exercise34.102,93299,98130,313Dec 23 02:08 PM
SEALE DONALD WExec. V.P. and CMODec 06Option Exercise49.437,977394,263151,801Dec 09 04:15 PM
SEALE DONALD WExec. V.P. and CMODec 06Sale89.677,977715,302143,824Dec 09 04:15 PM
Earhart Cynthia CExec. VP - AdministrationNov 25Sale87.2229926,0790Nov 25 01:53 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 06Option Exercise40.364,955199,968139,400Nov 07 02:46 PM
Earhart Cynthia CExec. VP - AdministrationOct 29Option Exercise34.102,00068,20045,172Oct 30 02:55 PM
Earhart Cynthia CExec. VP - AdministrationOct 29Sale88.482,000176,96043,172Oct 30 02:55 PM
Allison Clyde H JrVice President & ControllerOct 28Option Exercise34.102,93299,98123,951Oct 30 02:56 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 28Option Exercise49.437,977394,263142,422Oct 29 03:35 PM
SEALE DONALD WExec. V.P. and CMOOct 28Option Exercise49.4312,023594,237154,074Oct 29 03:35 PM
SEALE DONALD WExec. V.P. and CMOOct 28Sale87.7410,000877,413144,074Oct 29 03:35 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 28Sale88.007,977701,976134,445Oct 29 03:35 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 24Option Exercise49.4310,000494,250144,445Oct 25 02:30 PM
RATHBONE JOHN PEVP Finance and CFOOct 24Option Exercise46.64125,0005,830,615244,439Oct 28 03:28 PM
RATHBONE JOHN PEVP Finance and CFOOct 24Sale84.52116,4079,838,720123,392Oct 28 03:28 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 24Sale86.9510,000869,500134,445Oct 25 02:30 PM
WLP [NYSE]
WellPoint Inc.
IndexS&P 500 P/E14.82 EPS (ttm)8.12 Insider Own0.20% Shs Outstand274.25M Perf Week-0.47%
Market Cap33.00B Forward P/E12.95 EPS next Y9.29 Insider Trans-7.43% Shs Float273.26M Perf Month8.04%
Income2.39B PEG1.49 EPS next Q2.27 Inst Own90.10% Short Float4.72% Perf Quarter13.86%
Sales72.16B P/S0.46 EPS this Y6.30% Inst Trans-0.83% Short Ratio7.50 Perf Half Y24.11%
Book/sh88.07 P/B1.37 EPS next Y6.62% ROA6.40% Target Price120.42 Perf Year37.30%
Cash/sh6.51 P/C18.49 EPS next 5Y9.94% ROE16.00% 52W Range80.11 - 121.33 Perf YTD31.87%
Dividend1.75 P/FCF11.02 EPS past 5Y12.70% ROI8.20% 52W High-0.83% Beta0.64
Dividend %1.45% Quick Ratio- Sales past 5Y3.00% Gross Margin- 52W Low50.20% ATR1.87
Employees48200 Current Ratio- Sales Q/Q4.40% Oper. Margin6.30% RSI (14)64.63 Volatility1.49% 1.45%
OptionableYes Debt/Eq0.61 EPS Q/Q-3.00% Profit Margin5.40% Rel Volume1.14 Prev Close118.40
ShortableYes LT Debt/Eq0.58 EarningsJul 30 BMO Payout12.10% Avg Volume1.72M Price120.32
Recom2.50 SMA203.70% SMA506.27% SMA20020.61% Volume1,948,000 Change1.62%
31-Jul-14Reiterated Barclays Equal Weight $110 → $120
24-Mar-14Reiterated UBS Buy $107 → $120
24-Mar-14Reiterated Stifel Buy $95 → $112
24-Mar-14Reiterated Oppenheimer Outperform $100 → $111
24-Mar-14Reiterated FBR Capital Mkt Perform $93 → $105
24-Mar-14Reiterated Deutsche Bank Hold $90 → $100
12-Mar-14Reiterated UBS Buy $98 → $107
30-Jan-14Upgrade UBS Neutral → Buy $98
29-Jan-14Downgrade Monness Crespi & Hardt Neutral → Sell $69
25-Nov-13Reiterated UBS Neutral $87 → $98
13-Nov-13Initiated FBR Capital Mkt Perform $93
05-Nov-13Downgrade Monness Crespi & Hardt Buy → Neutral
16-Jul-13Reiterated Deutsche Bank Hold $76 → $85
13-May-13Reiterated Monness Crespi & Hardt Buy $90 → $109
25-Apr-13Upgrade Monness Crespi & Hardt Neutral → Buy $90
25-Apr-13Reiterated Deutsche Bank Hold $71 → $76
25-Apr-13Reiterated Barclays Equal Weight $72 → $81
05-Apr-13Initiated UBS Neutral $70
02-Apr-13Reiterated Deutsche Bank Hold $68 → $71
13-Feb-13Downgrade Monness Crespi & Hardt Buy → Neutral
17-Sep-14 12:01AM  Hospitals and Insurer Join Forces in California at New York Times
15-Sep-14 11:04AM  Why Thomas Lee is bullish on stocks at CNBC
11-Sep-14 11:56AM  Moody's Affirms Ten CMBS Classes of COMM 2013-LC13 at Moody's
10-Sep-14 06:45PM  Keep betting on this part of the market: Pro at CNBC
09-Sep-14 05:46PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
06:03AM  WELLPOINT, INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
05-Sep-14 06:13PM  Today's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
02:35AM  As Many Predicted, Obamacare's Healthcare.Gov Reports Hack Attack; Security Remains Compromised at Forbes
03-Sep-14 05:18PM  WellPoint Announces Appearances at Upcoming Conferences Business Wire
02-Sep-14 01:03PM  WLP, UNH And ESRX, Pushing Health Services Industry Downward at TheStreet
05:00AM  Americans want to safeguard their familys financial wellbeing Business Wire
29-Aug-14 11:13AM  WellPoint Reaches 52-Week High, Driven by Strong Q2 Results Zacks
27-Aug-14 12:01AM  Insurers pay more tax on executive comp under Obamacare -study Reuters
26-Aug-14 01:03PM  3 Health Services Stocks Moving The Industry Upward at TheStreet
25-Aug-14 06:22PM  ObamaCare '15 Rates Count On Federal Aid Investor's Business Daily
10:15AM  Insider Trading Alert - WLP, COST And COF Traded By Insiders at TheStreet
21-Aug-14 06:00AM  This one stock sector can withstand all the bubble talk at MarketWatch
13-Aug-14 04:02PM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
01:54PM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
01:01PM  Health insurance giant WellPoint renames itself Anthem at Los Angeles Times
12:44PM  WellPoint: What's in a Name? at Barrons.com
09:54AM  Insurer WellPoint plans name change to Anthem AP
09:09AM  Insurer WellPoint plans name change to Anthem AP
06:00AM  WellPoint Announces Intent to Change Corporate Name to Anthem, Inc. Business Wire
12:48AM  PRESS DIGEST - Wall Street Journal - Aug 13 Reuters
12:46AM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
12-Aug-14 10:40PM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
08:51PM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
08:41PM  U.S. health insurer WellPoint to change name to Anthem Inc Reuters
08:38PM  [audio] Newscast: Want a bigger 401(k) match? at MarketWatch
06:55PM  WellPoint Will Change Name to Anthem to Reach Consumers at Bloomberg
06:35PM  Health insurer Wellpoint changes name to Anthem AP
05:16PM  [$$] WellPoint Changes Its Name to Anthem at The Wall Street Journal
05:00PM  [$$] Wellpoint Changes Its Name to Anthem at The Wall Street Journal
04:26PM  WELLPOINT, INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online
08-Aug-14 02:00PM  A.M. Best Assigns Debt Ratings to WellPoint, Inc.s New Senior Unsecured Notes Business Wire
07-Aug-14 04:51PM  [video] U.S. Markets End Lower on Ukraine Conflict Concerns at TheStreet
06-Aug-14 01:04PM  WELLPOINT, INC Financials EDGAR Online Financials
11:08AM  Health Net Q2 Earnings Beat on Higher Revs, Guides In-Line Zacks
08:27AM  MOVES-Evercore hires Barclays' Mark Hanson as senior managing director Reuters
05-Aug-14 12:40PM  Gentiva Q2 Earnings Beat Estimates, Up Y/Y; Outlook Revised Zacks
10:10AM  5 Affordable Care Act Stock Winners to Buy Now at 24/7 Wall St.
12:01AM  [$$] Two Insurers to Pool Medical Records in California at The Wall Street Journal
04-Aug-14 05:26PM  Consumer Transparency on MRI Costs Saved $220 Per Test in Overall Costs, Increased Competition among Hospitals Business Wire
01-Aug-14 04:15PM  Don't expect U.S. to follow California's lead on Obamacare rates, chief says at MarketWatch
01:40PM  DaVita Healthcare Beats on Q2 Earnings, Revises Guidance Zacks
11:10AM  Obamacare Becomes a Long-Term Tailwind for Creating Value for Senior Housing REITs: A Wall Street Transcript Interview with Dana Hambly, CFA, Research Associate on the Health Care Services Team with Stephens Inc. Wall Street Transcript
31-Jul-14 02:56PM  Californias Obamacare Rates to Average 4.2% Rise in 2015 at Bloomberg
02:05PM  Molina Healthcare (MOH) Q2 Earnings Beat, Maintains Outlook Zacks
30-Jul-14 03:31PM  US STOCKS-S&P 500 nearly flat as investors digest Fed statement Reuters
02:33PM  US STOCKS-S&P 500 turns higher after Fed statement Reuters
02:32PM  15 Stocks That Benefit From Dollar Strength at Barrons.com
01:22PM  [video] Humana and WellPoint Slide After Reporting Lower Quarterly Profit at TheStreet
01:16PM  WellPoint, Humana Q2 Profit Down, Membership Up at Investor's Business Daily
12:04PM  [$$] WellPoint Lifts View Despite Profit Drop at The Wall Street Journal
10:50AM  Humana (HUM) Q2 Earnings in Line with Estimates, Down Y/Y Zacks
10:40AM  Why WellPoint (WLP) Stock Is Lower Today at TheStreet
10:36AM  WellPoint (WLP) Q2 Earnings Beat, Down Y/Y on High Expenses Zacks
10:29AM  WellPoint 2Q tops Wall Street expectations AP
09:59AM  Water-Logged And Getting Wetter: WellPoint (WLP) at TheStreet
09:31AM  Wellpoint, Humana Obamacare Enrollment On The Rise at Forbes
09:25AM  WellPoint says exchange business costs are as planned Reuters
09:05AM  US STOCKS-Futures point to higher open after GDP data Reuters
08:30AM  WellPoint, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:22AM  [video] Obamacare not affordable for many: Aetna CEO at CNBC
08:17AM  WellPoint medical cost ratio drives 2nd-quarter profit beat Reuters
08:03AM  [video] Aetna CEO: Utilization numbers up at CNBC
07:22AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Medtronic, Wright Medical Group, Cardinal Health and WellPoint Zacks
07:07AM  Q2 2014 WellPoint, Inc. Earnings Release - 06:00 am ET CCBN
07:05AM  WellPoint 2Q tops Wall Street expectations AP
06:38AM  [$$] WellPoint Profit Slips, But Boosts Outlook at The Wall Street Journal
06:29AM  Obamacare Is Good News for WellPoint This Quarter at Bloomberg
06:24AM  WellPoint 2nd-quarter profit falls but beats estimates Reuters
06:10AM  WELLPOINT, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:57AM  WellPoint says second-quarter profit fell Reuters
05:30AM  WellPoint Reports Second Quarter 2014 Results Business Wire
29-Jul-14 03:07PM  Humana, WellPoint, Garmin, 3 Others Report Earnings Early Wednesday at TheStreet
10:44AM  Top 3 MedTech Stocks, Poised to Gain on Earnings Zacks
09:43AM  Aetna 2Q profit beats expectations at USA TODAY
08:32AM  Aetna 2Q profit beats expectations at USA TODAY
07:24AM  Is a Surprise Coming for WellPoint (WLP) This Earnings Season? Zacks
25-Jul-14 01:03PM  BAX, WLP And COV, 3 Health Services Stocks Pushing The Industry Lower at TheStreet
12:11PM  WellCare profit warning sinks managed care names at theflyonthewall.com
23-Jul-14 07:23AM  [video] Court deals blow for Obamacare subsidies at CNBC
22-Jul-14 04:38PM  Did 3 Judges Just Start the Obamacare Death Spiral? at Motley Fool
11:26AM  [video] Long way from ACA ruling having impact: Expert at CNBC
10:49AM  [video] Is ACA legislation slowly being dismantled? at CNBC
10:44AM  [video] US appeals court strikes blow against ACA subsides at CNBC
10:43AM  Appeals court bars subsidies in health care law theflyonthewall.com
21-Jul-14 09:41AM  Follow Goldman with These Equity ETFs Zacks
12:01AM  Where Is The Value In Health Care? at Forbes
18-Jul-14 02:06PM  UnitedHealth Shares Hit 52-Week High on Q2 Earnings Strength Zacks
17-Jul-14 01:45PM  3 Stocks Near 52-Week Highs Worth Selling at Motley Fool
09:52AM  UnitedHealth To Expand On Obamacare Exchanges In 2015 'And Beyond' at Forbes
16-Jul-14 12:32PM  Why UnitedHealth Group Will Move the Dow Tomorrow at Motley Fool
14-Jul-14 12:58PM  The Doctor Will Click on You Now, but Can She Feel Your Pain in an E-Visit? Bloomberg
13-Jul-14 08:17PM  The Doctor Will Click on You Now, but Can She Feel Your Pain in an E-Visit? Bloomberg
08:17PM  The Doctor Will Click on You Now, as the Mouse Replaces the Stethoscope Bloomberg
08:17PM  The Doctor Will Click on You Now, as Mouse Clicks Replace Stethoscopes Bloomberg
08:17PM  Mouse Clicks Replace Stethoscopes as U.S. Web Care Grows Bloomberg
WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as behavioral health benefit services, dental, vision, life and disability insurance benefits, radiology benefit management, analytics-driven personal health care guidance, and long-term care insurance. Further, the company provides services to the federal Government in connection with the federal Employee Program and various medicare programs; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2013, it served 35.7 million medical members through its affiliated health plans; and approximately 67.8 million individuals. WellPoint, Inc. is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 11Option Exercise63.3620,0001,267,200123,758Sep 15 04:08 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 11Sale120.0020,0002,400,000103,758Sep 15 04:08 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 09Option Exercise65.984,404290,576126,179Sep 11 04:23 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 09Option Exercise63.3620,0001,267,200123,758Sep 09 04:11 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 09Sale120.004,404528,480121,775Sep 11 04:23 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 09Sale120.0020,0002,400,000103,758Sep 09 04:11 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 08Option Exercise74.8626,9382,016,444148,713Sep 09 04:12 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 08Sale117.9626,9383,177,728121,775Sep 09 04:12 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 05Option Exercise80.8637,5983,040,028159,373Sep 09 04:12 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 05Option Exercise70.8018,2441,291,675122,002Sep 09 04:11 PM
DeVeydt Wayne SEVP & Chief Financial OfficerSep 05Sale118.0337,5984,437,788121,775Sep 09 04:12 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerSep 05Sale119.0018,2442,171,036103,758Sep 09 04:11 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerAug 28Option Exercise70.805,000354,000108,758Aug 29 04:12 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerAug 28Sale116.005,000580,000103,758Aug 29 04:12 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerAug 27Option Exercise70.8035,0002,478,000138,758Aug 29 04:12 PM
NUSSBAUM SAMUEL R MDEVP & Chief Medical OfficerAug 27Sale116.0635,0004,062,100103,758Aug 29 04:12 PM
DeVeydt Wayne SEVP & Chief Financial OfficerAug 05Option Exercise76.5930,0002,297,700151,775Aug 07 04:15 PM
DeVeydt Wayne SEVP & Chief Financial OfficerAug 05Sale110.9530,0003,328,524121,775Aug 07 04:15 PM
PERU RAMIRO GDirectorJun 05Sale108.425,372582,43220,686Jun 09 04:11 PM
Gallina John ESVP & Chief Accounting OfficerJun 02Option Exercise76.5914,6671,123,34637,158Jun 04 04:10 PM
Gallina John ESVP & Chief Accounting OfficerJun 02Sale108.3414,6671,589,02322,491Jun 04 04:10 PM
RYAN WILLIAM JDirectorMay 30Sale108.185,372581,14332,573Jun 03 04:06 PM
SCHAEFER GEORGE A JRDirectorJan 31Option Exercise44.1810,000441,80043,055Feb 03 04:14 PM
SCHAEFER GEORGE A JRDirectorJan 31Sale86.7010,000867,00033,055Feb 03 04:14 PM
ZORETIC RICHARD CEVP, Gov Business DivisionDec 26Sale91.7920,0001,835,80024,432Dec 27 04:04 PM
ZORETIC RICHARD CEVP, Gov Business DivisionDec 16Sale87.6988977,95662,522Dec 18 04:01 PM
Cannon JohnEVP, GC & Chief PAODec 13Sale87.739,558838,52399,331Dec 16 04:14 PM
MCCARTHY GLORIA MEVP & Chief Administrative OffDec 11Option Exercise80.8129,7492,404,01787,008Dec 12 04:08 PM
MCCARTHY GLORIA MEVP & Chief Administrative OffDec 11Sale90.0929,7492,680,08757,259Dec 12 04:08 PM
MCCARTHY GLORIA MEVP & Chief Administrative OffDec 10Option Exercise78.2482,1186,424,956139,377Dec 12 04:08 PM
MCCARTHY GLORIA MEVP & Chief Administrative OffDec 10Sale91.3282,1187,499,01657,259Dec 12 04:08 PM
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E14.57 EPS (ttm)5.72 Insider Own0.10% Shs Outstand354.60M Perf Week-1.87%
Market Cap29.56B Forward P/E11.60 EPS next Y7.19 Insider Trans15.66% Shs Float353.13M Perf Month7.24%
Income2.10B PEG1.43 EPS next Q1.59 Inst Own90.10% Short Float1.52% Perf Quarter3.73%
Sales54.72B P/S0.54 EPS this Y10.80% Inst Trans-1.10% Short Ratio2.46 Perf Half Y13.70%
Book/sh41.19 P/B2.02 EPS next Y9.16% ROA4.10% Target Price89.37 Perf Year22.77%
Cash/sh4.96 P/C16.79 EPS next 5Y10.16% ROE14.80% 52W Range59.78 - 85.72 Perf YTD22.61%
Dividend0.90 P/FCF9.86 EPS past 5Y13.50% ROI9.70% 52W High-2.76% Beta1.05
Dividend %1.08% Quick Ratio- Sales past 5Y8.80% Gross Margin- 52W Low39.42% ATR1.31
Employees48600 Current Ratio- Sales Q/Q25.80% Oper. Margin7.00% RSI (14)55.99 Volatility1.64% 1.47%
OptionableYes Debt/Eq0.56 EPS Q/Q2.00% Profit Margin3.80% Rel Volume0.71 Prev Close82.12
ShortableYes LT Debt/Eq0.52 EarningsJul 29 BMO Payout14.70% Avg Volume2.18M Price83.35
Recom2.10 SMA202.17% SMA502.91% SMA20012.11% Volume1,552,300 Change1.50%
29-Jul-14Reiterated FBR Capital Outperform $80 → $93
25-Apr-14Reiterated Barclays Overweight $80 → $87
12-Mar-14Reiterated UBS Buy $82 → $86
08-Jan-14Reiterated Barclays Overweight $75 → $80
13-Dec-13Reiterated FBR Capital Outperform $71 → $75
25-Nov-13Reiterated UBS Buy $76 → $82
13-Nov-13Initiated FBR Capital Outperform
05-Nov-13Downgrade Monness Crespi & Hardt Buy → Neutral
30-Oct-13Reiterated Deutsche Bank Buy $79 → $73
30-Oct-13Reiterated Barclays Overweight $78 → $75
16-Oct-13Reiterated Deutsche Bank Buy $72 → $79
17-Sep-13Reiterated UBS Buy $73 → $76
06-Aug-13Reiterated Cantor Fitzgerald Hold $60 → $65
01-Aug-13Reiterated UBS Buy $68 → $73
23-Jul-13Initiated Stifel Buy $80
16-Jul-13Reiterated Deutsche Bank Buy $68 → $72
01-May-13Reiterated Cantor Fitzgerald Hold $55 → $60
01-May-13Reiterated Barclays Overweight $57 → $69
17-Apr-13Reiterated Deutsche Bank Buy $60 → $61
02-Apr-13Reiterated Deutsche Bank Buy $55 → $60
16-Sep-14 03:20PM  Aetna Poised for Organic & Inorganic Growth, Risks Remain Zacks
14-Sep-14 03:46PM  Insurers Fight Hospital Mergers As ACA Snubs Fee For Service Medicine at Forbes
11-Sep-14 12:07PM  Coventry Health Care, CHI Health and UniNet Expand Collaboration to Deliver High-Quality, Lower-Cost Health Care to Omaha Residents Business Wire
10-Sep-14 03:00PM  Aetna Forms ACO in New York with Weill Cornell Physicians Zacks
12:59PM  For Now, Blue Cross Brand Dominates Obamacare Exchanges at Forbes
12:59PM  For Now, Blue Cross Brand Dominates Key Obamacare Exchanges at Forbes
12:59PM  For now, Blue Cross Brand Dominates Key Obamacare Exchanges at Forbes
12:31PM  Coventry Health Care, CHI Health St. Elizabeth, CHI Health Nebraska Heart and UniNet Expand Collaboration to Deliver High-Quality, Lower-Cost Health Care Plan to Lincoln Residents Business Wire
11:38AM  Coventry Health Care and Mercy Medical Center Des Moines Expand Health Care Plan to Offer Des Moines Residents Greater Value Business Wire
09-Sep-14 03:34PM  Aetna Announces Accountable Care Agreement with Weill Cornell Physicians Business Wire
11:08AM  ObamaCare, Government Giveaways, Inefficiencies and Abuse Top $850 Billion Yahoo Finance Blogs
07:49AM  AETNA INC /PA/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
06-Sep-14 12:01AM  Iraq Pursues New Tack in Bid to Seize Tanker Off Texas at Bloomberg
05-Sep-14 02:35AM  As Many Predicted, Obamacare's Healthcare.Gov Reports Hack Attack; Security Remains Compromised at Forbes
04-Sep-14 03:10PM  Aetna Forms ACO with Baylor Scott & White Quality Alliance Zacks
07:00AM  21 Super Solid Dividend Payers at Forbes
03-Sep-14 10:00AM  Aetna and Baylor Scott & White Quality Alliance Announce Accountable Care Collaboration in Dallas Business Wire
01-Sep-14 10:51AM  Five Ways ACA And Employers Shift Costs This Open Enrollment Season at Forbes
29-Aug-14 06:03PM  Despite Regulation, Transparency and Competition, Aetna Looks Competitive in the Industry Gurufocus
01:08PM  Aetna Announces Appearance at Morgan Stanley Global Healthcare Conference Business Wire
28-Aug-14 06:05PM  Another GOP Holdout State Expands Medicaid Under Obamacare at Forbes
27-Aug-14 11:34AM  Should Your Health App Be Culturally Sensitive? at Forbes
11:30AM  Lower Costs, More Proactive Care in Aetna and Banner Health Network Accountable Care Collaboration Business Wire
12:01AM  Insurers pay more tax on executive comp under Obamacare -study Reuters
26-Aug-14 11:46AM  The 10 most influential people in health care at MarketWatch
25-Aug-14 02:07PM  Business events scheduled for Tuesday AP
24-Aug-14 10:08AM  Hospice Oversight May Come From Rare Bipartisan Health Bill at Forbes
21-Aug-14 04:39PM  Aetna and Washington Hospital Healthcare System Reach New Agreement Business Wire
20-Aug-14 01:29PM  Aetna, Alegent Creighton Health and UniNet Create Patient-Centric Health Care Network in Omaha Business Wire
18-Aug-14 12:24PM  Medicaid Program CoventryCares Changes Name to Aetna Better Health of Nebraska Business Wire
14-Aug-14 04:03PM  WellCare To Appoint Andrew Asher As Senior Vice President; Appointment As Chief Financial Officer Expected In November Thomson Reuters ONE
13-Aug-14 01:00AM  Bull of the Day: Gilead Sciences (GILD) Zacks
12-Aug-14 03:32PM  NIST is Starting Point for Cybersecurity at The Wall Street Journal
11-Aug-14 01:04PM  3 Health Services Stocks Dragging The Industry Down at TheStreet
08:02AM  ObamaCare Enrollment Is Shrinking, Top Insurers Say at Investor's Business Daily
08:02AM  ObamaCare Enrollment Falling Significantly, Insurers Reveal Investor's Business Daily
07-Aug-14 07:06PM  Aetna and UnitedHealth Investor's Business Daily
04:51PM  [video] U.S. Markets End Lower on Ukraine Conflict Concerns at TheStreet
12:07PM  [video] Trader blitz: Fox flying higher at CNBC
06-Aug-14 11:33AM  Whether You Go With Aetna, Allstate, AIG Or Another, Avoid The Four Big Insurance Traps at Forbes
05-Aug-14 01:04PM  AETNA INC /PA/ Financials EDGAR Online Financials
01:04PM  3 Stocks Underperforming Today In The Health Services Industry at TheStreet
10:10AM  5 Affordable Care Act Stock Winners to Buy Now at 24/7 Wall St.
04-Aug-14 03:12PM  Health Net Appeal Grows as Obamacare Takes Off: Real M&A at Bloomberg
03-Aug-14 07:00AM  Aetna CEO takes health care personally at CNBC
01-Aug-14 04:26PM  Aetna and NYUPN Clinically Integrated Network, LLC Announce Collaboration Serving 24,000 New Yorkers Business Wire
01:40PM  DaVita Healthcare Beats on Q2 Earnings, Revises Guidance Zacks
11:10AM  Obamacare Becomes a Long-Term Tailwind for Creating Value for Senior Housing REITs: A Wall Street Transcript Interview with Dana Hambly, CFA, Research Associate on the Health Care Services Team with Stephens Inc. Wall Street Transcript
31-Jul-14 02:56PM  Californias Obamacare Rates to Average 4.2% Rise in 2015 at Bloomberg
30-Jul-14 11:53AM  Many Americans can't afford Obamacare: Aetna CEO at CNBC
10:50AM  Humana (HUM) Q2 Earnings in Line with Estimates, Down Y/Y Zacks
09:37AM  It does not feel like a 4% economy: Aetna CEO at CNBC
08:22AM  [video] Obamacare not affordable for many: Aetna CEO at CNBC
08:03AM  [video] Aetna CEO: Utilization numbers up at CNBC
07:35AM  #PreMarket Primer: Wednesday, July 30: U.S. Economy Showing Signs Of Strength Benzinga
06:48AM  What Falling Estimates & Price Mean for WellCare Health Plans (WCG) Zacks
29-Jul-14 08:55PM  [$$] Aetna's Profit Rises Despite Higher Medical Costs at The Wall Street Journal
02:50PM  US STOCKS-Wall St edges lower on UPS outlook, telecom shares rally Reuters
02:16PM  Why Aetna (AET) Stock Is Lower Today at TheStreet
01:50PM  Aetna Q2 Earnings Beat on Higher Underwriting, Guides Up Zacks
01:35PM  Aetna says medical costs rose, insurer shares drop Reuters
12:11PM  Aetna 2Q profit rises 2.4 percent AP
11:28AM  Aetna Posts Higher Profit With the Affordable Care Act at TheStreet
11:12AM  [$$] Aetna's Profit, Medical Costs Rise at The Wall Street Journal
11:03AM  Aetna Earnings Beat But Rising Medical Costs A Worry at Investor's Business Daily
09:57AM  Wall Street Closes Lower, Pulled Down in Part by UPS at New York Times
09:57AM  Shares Decline as Weak Results From UPS Outweigh Telecommunications Strength at New York Times
09:54AM  As Profits Roll In, Aetna To Expand On Obamacare Exchange In 2015 at Forbes
09:49AM  [video] The Top Ten Stocks for Tuesday, July 29 at Bloomberg
09:43AM  Aetna 2Q profit beats expectations at USA TODAY
09:27AM  [video] Tues. July 29: Merck Among Stocks to Watch at MarketWatch
09:24AM  [$$] Aetna's Profit, Medical Costs Rise at The Wall Street Journal
09:08AM  [video] Aetna Thrives Under Obamacare, Profits Rise in Q2 at TheStreet
09:03AM  UPS delivers a profit miss; Darden CEO steps down; Herbalife tumbles Hot Stock Minute
08:58AM  Aetna to sell Obamacare exchange plans in Georgia Reuters
08:32AM  Aetna 2Q profit beats expectations at USA TODAY
08:30AM  Aetna Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  Aetna Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:14AM  Stock Market Today: Futures Higher as Aetna, Merck Top Expectations at TheStreet
07:59AM  Twitter earnings preview; Argentina debt deadline; More than 1 in 3 facing debt collection Hot Stock Minute
07:41AM  Aetna says Coventry purchase boosted second-quarter profit Reuters
07:39AM  Aetna 2Q profit rises 2.4 percent AP
07:34AM  Aetna Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q2 2014 Aetna Inc. Earnings Release - 06:00 am ET CCBN
07:03AM  [$$] Aetna Beats Street, Raises Outlook at The Wall Street Journal
06:53AM  Aetna says Coventry purchase boosted second-quarter profit Reuters
06:41AM  AETNA INC /PA/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:31AM  AETNA INC /PA/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:25AM  Aetna profit rises; raises 2014 earnings projection at MarketWatch
06:25AM  Aetna 2Q profit rises 2.4 percent AP
06:24AM  [$$] Aetna Beats Street, Raises Outlook at The Wall Street Journal
06:15AM  Aetna says second-quarter profit rose Reuters
06:13AM  Aetna Raises Forecast on Customer Growth, Cost Savings at Bloomberg
06:00AM  Aetna Reports Second-Quarter 2014 Results Business Wire
05:52AM  U.S. stocks: Futures decline before confidence report at MarketWatch
12:26AM  Aetna Inc. Earnings Call scheduled for 8:30 am ET today CCBN
28-Jul-14 04:36PM  Why the Fed could start raising rates sooner than you think at CNBC
03:00PM  Will Growth Measures at Aetna (AET) Drive Q2 Earnings Beat? Zacks
10:33AM  Aetna and Geisinger Health System Reach New Agreement Business Wire
27-Jul-14 11:00AM  Any Insurer Angst On Obamacare Subsidies May Emerge This Week at Forbes
Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment provides medical, pharmacy benefit management, dental, behavioral health, and vision plans on an insured basis, and an employer-funded or administrative basis. This segment also provides Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select markets. This segment offers its products and services to multi-site national, mid-sized, and small employers, as well as individual customers. The Group Insurance segment provides life insurance products comprising group term life insurance, voluntary spouse and dependent term life insurance, group universal life, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which offer benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. This segment provides insurance products principally to employers that sponsor its products for the benefit of their employees and their employees' dependents. The Large Case Pensions segment manages various retirement products, including pension and annuity products for tax-qualified pension plans. The company's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is headquartered in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casazza William JamesExec. VP & General CounselJun 12Sale80.5815,9061,281,62633,903Jun 13 04:24 PM
Casazza William JamesExec. VP & General CounselJun 11Option Exercise50.7082,8414,200,039116,744Jun 13 04:24 PM
HACKMAN FRANKLIN BARBARADirectorMay 27Sale77.262,665205,90626,109May 27 04:36 PM
Parmeswar RajanVP/Controller/Chief Acct OffFeb 19Sale69.463,600250,0583,829Feb 20 07:35 PM
Casazza William JamesExec. VP & General CounselFeb 14Sale68.9221,7051,495,96533,903Feb 18 06:02 PM
Coye Molly JoelDirectorFeb 14Sale68.4775051,3538,700Feb 18 05:59 PM
Bertolini Mark TChairman, CEO and PresidentDec 30Option Exercise33.38130,2724,347,828657,210Jan 02 04:31 PM
Bertolini Mark TChairman, CEO and PresidentDec 30Sale68.08130,2728,868,384526,938Jan 02 04:31 PM
Coye Molly JoelDirectorDec 27Sale68.2937025,2679,450Dec 30 04:02 PM
Casazza William JamesSr. VP & General CounselDec 27Sale68.2510,299702,90733,903Dec 30 04:02 PM
Casazza William JamesSr. VP & General CounselDec 26Option Exercise50.2175,6783,799,414109,581Dec 30 04:02 PM
Reisman LonnySVP, Chief Medical OfficerNov 21Sale67.0927,4891,844,18269,320Nov 22 04:31 PM
Reisman LonnySVP, Chief Medical OfficerNov 20Option Exercise37.16190,6527,085,078141,320Nov 22 04:31 PM
Zubretsky Joseph MSr. EVP, National BusinessesNov 20Option Exercise32.116,921222,233344,581Nov 22 04:31 PM
Reisman LonnySVP, Chief Medical OfficerNov 20Sale65.8072,0004,737,38469,320Nov 22 04:31 PM
McCarthy Margaret MEVP, Operations & TechnologyNov 12Option Exercise41.5412,460517,58880,363Nov 13 04:33 PM
McCarthy Margaret MEVP, Operations & TechnologyNov 12Sale63.0344,4002,798,49635,963Nov 13 04:33 PM
McCarthy Margaret MEVP, Operations & TechnologyNov 11Option Exercise44.82201,6139,036,357122,752Nov 13 04:33 PM
HACKMAN FRANKLIN BARBARADirectorNov 04Sale62.684,367273,73525,943Nov 05 04:22 PM
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E24.00 EPS (ttm)4.38 Insider Own0.10% Shs Outstand245.89M Perf Week-0.54%
Market Cap25.85B Forward P/E21.69 EPS next Y4.85 Insider Trans-5.02% Shs Float231.81M Perf Month2.04%
Income1.09B PEG3.49 EPS next Q1.26 Inst Own71.30% Short Float1.22% Perf Quarter4.34%
Sales10.73B P/S2.41 EPS this Y15.20% Inst Trans1.49% Short Ratio3.06 Perf Half Y10.48%
Book/sh45.56 P/B2.31 EPS next Y8.53% ROA2.90% Target Price108.67 Perf Year26.81%
Cash/sh3.21 P/C32.77 EPS next 5Y6.88% ROE9.90% 52W Range82.61 - 107.81 Perf YTD18.69%
Dividend2.64 P/FCF- EPS past 5Y-2.00% ROI5.70% 52W High-2.48% Beta0.44
Dividend %2.51% Quick Ratio1.00 Sales past 5Y-0.40% Gross Margin98.50% 52W Low27.28% ATR1.38
Employees17122 Current Ratio1.10 Sales Q/Q1.70% Oper. Margin17.00% RSI (14)53.23 Volatility1.44% 1.22%
OptionableYes Debt/Eq1.23 EPS Q/Q9.10% Profit Margin10.20% Rel Volume0.56 Prev Close104.31
ShortableYes LT Debt/Eq1.10 EarningsAug 07 BMO Payout57.20% Avg Volume926.48K Price105.14
Recom2.00 SMA200.34% SMA502.36% SMA2009.22% Volume526,700 Change0.80%
14-Aug-14Reiterated UBS Buy $106 → $111
14-Apr-14Initiated UBS Buy $106
02-Apr-14Reiterated RBC Capital Mkts Outperform $102 → $104
06-Jan-14Reiterated Barclays Overweight $101 → $97
28-May-13Upgrade Barclays Equal Weight → Overweight $85 → $90
24-Apr-13Reiterated Barclays Equal Weight $77 → $85
23-Apr-13Downgrade ISI Group Buy → Neutral
27-Feb-13Reiterated Barclays Equal Weight $70 → $77
07-Jan-13Upgrade ISI Group Neutral → Buy
23-Jul-12Downgrade Argus Buy → Hold
03-Apr-12Reiterated Barclays Equal Weight $60 → $63
07-Nov-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
24-Jun-11Initiated RBC Capital Mkts Sector Perform $55
08-Apr-11Reiterated Barclays Capital Equal Weight $54 → $57
28-Feb-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
10-Dec-10Initiated Oppenheimer Perform $56
04-Aug-10Reiterated Barclays Capital Overweight $56 → $59
08-Mar-10Upgrade Barclays Capital Equal Weight → Overweight $56 → $57
17-Feb-10Reiterated Jefferies & Co Buy $62 → $58
13-Jan-10Downgrade Wells Fargo Outperform → Market Perform
16-Sep-14 05:14PM  SDG&E's Residential Rate Reform Proposal Seeks Fairness For All PR Newswire
04:18PM  California's Chief Energy Regulator Recuses Himself From Critical Utility Proceeding at Forbes
12-Sep-14 08:13PM  SDG&E Prepares For Heat Wave PR Newswire
02:08PM  Sempra Energy Declares Common Dividend PR Newswire
10-Sep-14 04:00PM  Sempra Energy President Mark Snell To Present At Wolfe Research Power & Gas Leaders Conference PR Newswire
02:43PM  Cameron LNG Receives Final Federal Regulatory Approval For Landmark Liquefaction-Export Project PR Newswire
02:16PM  U.S. approves LNG exports from Sempra, Carib Energy projects Reuters
09-Sep-14 12:00PM  San Diego Achieves Milestone With 10,000 Electric Vehicles On The Road PR Newswire
08-Sep-14 01:00PM  SDG&E To Procure More Local Energy Resources For Long-Term Regional Reliability PR Newswire
07-Sep-14 09:32PM  [$$] U.S. Natural Gas Fuels Mexican Boom at The Wall Street Journal
05-Sep-14 06:13PM  Today's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
02-Sep-14 02:17PM  SDG&E Air Assets Arrive For High-Risk Fire Season PR Newswire
29-Aug-14 03:11PM  [$$] U.S. Utilities Push Electric Cars at The Wall Street Journal
02:39PM  [$$] U.S. Utilities Push Electric Cars at The Wall Street Journal
28-Aug-14 12:00PM  SDG&E Continues To Warn Customers About Payment Scam PR Newswire
25-Aug-14 08:00AM  Geothermal Power Steaming Over Wind And Solar Energies at Forbes
18-Aug-14 03:05PM  Dennis W. Doll, the Chairman, President and CEO of Middlesex Water Company (MSEX), Interviews with The Wall Street Transcript Wall Street Transcript
15-Aug-14 01:04PM  SEMPRA ENERGY Financials EDGAR Online Financials
14-Aug-14 05:09PM  U.S. Energy Dept finalizes overhaul of natural gas export reviews Reuters
04:58PM  Southern California Gas Co. Declares Preferred Dividends PR Newswire
13-Aug-14 10:52AM  Energy Reformation in Mexico Creates Opportunity for Cogeneration Companies Accesswire
12-Aug-14 04:00PM  Why the hottest trade of the year is burning out Talking Numbers
11-Aug-14 08:00AM  SoCalGas Reminds Contractors, Customers and Business Owners to 'Call 811 Before You Dig' PR Newswire
07-Aug-14 06:02PM  Year's Gains In Utilities Are Fading Away at Investor's Business Daily
12:50PM  Sempra Energy Misses on Q2 Earnings and Revenues, Tweaks View Zacks
12:49PM  Mexico Oil Is Boon for Exxon to BP as Frontiers Teeter Bloomberg
12:09PM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
10:04AM  [$$] Sempra Energy Profit Rises at The Wall Street Journal
09:00AM  Sempra Energy Earnings Rise In Second Quarter 2014 PR Newswire
07:07AM  Q2 2014 Sempra Energy Earnings Release - 09:00 am ET CCBN
05:26AM  Shakeout May Be Ahead for LNG Plants, Say Japan Experts at The Wall Street Journal
12:19AM  Mexico Oil Is Boon for Exxon to BP as Frontiers Teeter Bloomberg
06-Aug-14 09:29PM  Cameron LNG project gets final investment approval-Japanese partners Reuters
06:00PM  Final Investment Decision Reached For Cameron LNG Liquefaction-Export Project PR Newswire
30-Jul-14 12:10AM  [$$] Project Exporting Gas to Japan Set For Green Light at The Wall Street Journal
29-Jul-14 07:32PM  "Solar Summer Tour" Heats Up Southern California As SoCalGas' Solar Water-Heated Unit Is Visiting 22 Locations PR Newswire
25-Jul-14 02:07PM  Sempra Energys Future Could be Fueled by LNG at Motley Fool
24-Jul-14 12:33PM  The 5 Best And 5 Worst Utilities At Renewables and Efficiency: Ceres Rankings at Forbes
09:00AM  Sempra Energy To Report Second-Quarter 2014 Earnings Aug. 7 PR Newswire
22-Jul-14 05:35PM  NRG Energy Buys 4-MW Caribbean Solar Project from Toshiba Zacks
19-Jul-14 03:18PM  Is This The Next Elephant in Warren Buffett's Crosshairs? at Motley Fool
18-Jul-14 08:33AM  Large-Scale Natural Gas Exports Inching Toward Reality at Seeking Alpha
17-Jul-14 02:26PM  Is Chesapeake Making a Mistake Betting on This Marginal Play? at Motley Fool
15-Jul-14 03:04PM  The hottest trade of the year could get hotter Talking Numbers
14-Jul-14 01:01PM  3 Areas Fueling Sempra Energys Surprising Growth at Motley Fool
12-Jul-14 07:26PM  FAA Approves Limited Use Of Drones For Utility Company at Forbes
11-Jul-14 04:13PM  Sempra Energy's Newest Tool: Drones at Motley Fool
03:26PM  First Drone Tests Approved for Southern California Utility at Bloomberg
01:00PM  FAA Approves Experimental Airspace For SDG&E To Test Unmanned Aircraft System PR Newswire
07-Jul-14 10:13AM  Midday Movers: GoPro, PetSmart, Tesla Motors & More at CNBC
02-Jul-14 11:02AM  Is Sempra Energy About to Become a Dividend Investors Dream Stock? at Motley Fool
01-Jul-14 11:02AM  LNG Exports Could Breathe New Life Into This Out-of-Favor Shale Gas Play at Motley Fool
30-Jun-14 01:54PM  Odebrecht wins $4 bln natgas pipeline contract in Peru Reuters
09:00AM  Current and upcoming liquefied natural gas export facilities Market Realist
26-Jun-14 08:10PM  SoCalGas Earns Top Marks in Greenlining Institute's 2014 Supplier Diversity Report Card PR Newswire
08:10PM  SoCalGas Earns Top Marks in Greenlining Institute's 2014 Supplier Diversity Report Card
01:30PM  SDG&E Has Adequate Power Supplies For Summer PR Newswire
01:30PM  SDG&E Has Adequate Power Supplies For Summer
10:04AM  Why the Coming LNG Boom Is the Real Deal at Motley Fool
10:04AM  Why the Coming LNG Boom Is the Real Deal
07:42AM  The Zacks Analyst Blog Highlights: Petrobras, YPF, Cheniere Energy, Dominion Resources, Sempra Energy and Energy Transfer Equity
25-Jun-14 12:07PM  Sempra Energy Releases Sixth Annual Corporate Responsibility Report PR Newswire
12:07PM  Sempra Energy Releases Sixth Annual Corporate Responsibility Report
06:00AM  Crumbling U.S. Grid Gets Jolt in Smart Houston Power System Bloomberg
06:00AM  Crumbling U.S. Grid Gets Jolt in Smart Houston Power System
06:00AM  Crumbling U.S. Grid Gets Jolt Driving Smart Houston Power
24-Jun-14 10:24AM  Why Sempra Energy's Gas Exports Won't Help Ukraine at Motley Fool
10:24AM  Why Sempra Energy's Gas Exports Won't Help Ukraine
23-Jun-14 05:29PM  Sempra Energy Wins Approval For LNG Export Facility at Investor's Business Daily
05:29PM  Sempra Energy Wins Approval For LNG Export Facility
02:47PM  Houston, a bright spot in U.S. economy, frets about labor shortage Reuters
02:47PM  Houston, a bright spot in U.S. economy, frets about labor shortage
22-Jun-14 04:16AM  An In-Depth Look At Sempra's Newly Approved LNG Export Facility at Seeking Alpha
04:16AM  An In-Depth Look At Sempra's Newly Approved LNG Export Facility
20-Jun-14 01:38PM  Chicago Bridge & Iron confirms FERC approval for Cameron LNG project at theflyonthewall.com
01:38PM  Chicago Bridge & Iron confirms FERC approval for Cameron LNG project
19-Jun-14 09:45PM  LNG Rally Fading on New Supply as Nukes Set to Restart at Bloomberg
06:39PM  [$$] Natural-Gas Facility Clears Hurdle at The Wall Street Journal
06:39PM  [$$] Natural-Gas Facility Clears Hurdle
02:38PM  [$$] Natural-Gas Export Facility Clears Federal Hurdle at The Wall Street Journal
02:08PM  FERC Approves Sempra's Cameron LNG Export Project at Motley Fool
02:08PM  FERC Approves Sempra's Cameron LNG Export Project
12:32PM  U.S. energy regulator approves Sempra LNG export project Reuters
12:32PM  U.S. energy regulator approves Sempra LNG export project
12:19PM  GDF Suez says U.S. regulators approve Cameron LNG project Reuters
12:19PM  GDF Suez says U.S. regulators approve Cameron LNG project
11:10AM  Sempras Cameron LNG Export Project Scores Another Approval 24/7 Wall St.
11:10AM  Sempras Cameron LNG Export Project Scores Another Approval
10:41AM  FERC Approves Cameron LNG Liquefaction-Export Project PR Newswire
10:41AM  FERC Approves Cameron LNG Liquefaction-Export Project
10:35AM  US FERC approves Sempra's Cameron LNG export project Reuters
10:35AM  US FERC approves Sempra's Cameron LNG export project
10:35AM  Sempra Wins Final U.S. Approval for Cameron LNG Exports at Bloomberg
10:35AM  Sempra Wins Final U.S. Approval for Cameron LNG Exports
17-Jun-14 02:49PM  Keystone Vote in Endangered Senators Campaign Strategy Bloomberg
09:26AM  Keystone Vote in Endangered Senators Campaign Strategy Bloomberg
16-Jun-14 06:19PM  Sempra Energy Declares Common Dividend PR Newswire
03:40PM  First Solar to Build 150MW Solar Plant in Imperial Valley, CA Zacks
13-Jun-14 12:26PM  SEMPRA ENERGY Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10:40AM  Sempra Unit Obtains Funding for Wind Project Zacks
Sempra Energy, through its subsidiaries, operates as an energy services company. The company's San Diego Gas & Electric Company segment generates, transmits, and distributes electricity; and distributes, transmits, and stores natural gas in California. As of December 31, 2013, this segment owned and operated 4 natural gas-fired power plants; 2,076 miles of electric transmission lines and 23,891 miles of electric distribution lines; and natural gas facilities consisted of 168 miles of transmission pipelines, 8,546 miles of distribution pipelines, and 6,460 miles of service pipelines. Its Southern California Gas Company segment offers distributes, transmits, and stores natural gas. This segment's natural gas facilities included 2,964 miles of transmission and storage pipelines, 49,832 miles of distribution pipelines, and 47,472 miles of service pipelines. The company's Sempra South American Utilities segment operates electric transmission and distribution utilities in Chile and Peru. Its Sempra Mexico segment develops, owns, operates, and holds interests in natural gas transmission pipelines, and propane and ethane systems; a natural gas distribution utility; electric generation facilities; a terminal for the import of liquefied natural gas (LNG); marketing for the purchase of LNG; and the purchase and sale of natural gas in Mexico. The company's Sempra Renewables segment develops, owns, operates, and holds interests in wind and solar energy projects in Arizona, California, Colorado, Hawaii, Indiana, Kansas, Nevada, and Pennsylvania to serve wholesale electricity markets in the United States. Its Sempra Natural Gas segment develops, owns, operates, and holds interests in a natural gas-fired electric generation asset; natural gas pipelines and storage facilities; natural gas distribution utilities; and a terminal for the import and export of LNG, and sale of natural gas in the United States. The company was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROWLAND G JOYCESenior VPSep 05Option Exercise61.414,250260,9934,367Sep 05 06:40 PM
ROWLAND G JOYCESenior VPSep 05Sale107.024,250454,835117Sep 05 06:40 PM
ROWLAND G JOYCESenior VPAug 11Option Exercise55.903,720207,9483,837Aug 11 03:07 PM
ROWLAND G JOYCESenior VPAug 11Sale101.483,720377,506117Aug 11 03:07 PM
REED DEBRA LChairman and CEOJun 19Option Exercise59.0736,3002,144,27194,063Jun 19 05:22 PM
SCHENK LYNNDirectorJun 19Option Exercise51.272,500128,1755,111Jun 19 05:28 PM
SCHENK LYNNDirectorJun 19Sale105.002,500262,5002,611Jun 19 05:28 PM
REED DEBRA LChairman and CEOJun 19Sale104.3136,3003,786,36357,763Jun 19 05:22 PM
BROCKSMITH JAMES G JRDirectorJun 18Option Exercise46.005,000230,0008,685Jun 18 08:14 PM
BROCKSMITH JAMES G JRDirectorJun 18Sale103.595,000517,9503,685Jun 18 08:14 PM
ROWLAND G JOYCESenior VPJun 09Option Exercise55.905,580311,9225,697Jun 09 05:43 PM
ROWLAND G JOYCESenior VPJun 09Sale101.095,580564,082117Jun 09 05:43 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFOJun 05Sale100.4717,1631,724,36716,553Jun 05 07:30 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFOJun 04Option Exercise49.5327,5001,361,96961,216Jun 05 07:30 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFOJun 04Sale99.9527,5002,748,62533,716Jun 05 07:30 PM
OUCHI WILLIAM GDirectorMay 13Sale97.5475473,54515,612May 13 04:03 PM
REED DEBRA LChairman and CEOMay 07Option Exercise46.1419,000876,66076,763May 07 01:02 PM
REED DEBRA LChairman and CEOMay 07Sale99.4019,0001,888,60057,763May 07 01:02 PM
OUCHI WILLIAM GDirectorMar 04Option Exercise46.005,000230,00020,750Mar 05 12:55 PM
RUSNACK WILLIAM CDirectorMar 03Option Exercise54.0020,0001,079,9005,884Mar 05 12:56 PM
BROCKSMITH JAMES G JRDirectorMar 03Option Exercise40.355,000201,7508,069Mar 05 12:54 PM
RUSNACK WILLIAM CDirectorMar 03Sale94.2320,0001,884,600884Mar 05 12:56 PM
BROCKSMITH JAMES G JRDirectorMar 03Sale94.255,000471,2503,069Mar 05 12:54 PM
ROWLAND G JOYCESenior VPJan 06Sale86.989,681842,0530Jan 08 02:41 PM
SNELL MARK APresidentJan 06Sale86.9825,1802,190,15660,904Jan 08 02:42 PM
REED DEBRA LChairman and CEOJan 06Sale86.9827,7762,415,95657,389Jan 08 02:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFOJan 06Sale86.9811,6481,013,14333,572Jan 08 02:40 PM
ROWLAND G JOYCESenior VPNov 07Option Exercise43.7512,200533,75012,200Nov 07 06:28 PM
ROWLAND G JOYCESenior VPNov 07Sale90.9912,2001,110,0780Nov 07 06:28 PM
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E23.18 EPS (ttm)4.93 Insider Own0.10% Shs Outstand191.84M Perf Week-1.09%
Market Cap21.93B Forward P/E16.75 EPS next Y6.82 Insider Trans0.52% Shs Float191.17M Perf Month-2.08%
Income974.80M PEG2.59 EPS next Q1.67 Inst Own86.00% Short Float3.41% Perf Quarter-2.47%
Sales8.34B P/S2.63 EPS this Y-12.10% Inst Trans-1.12% Short Ratio10.22 Perf Half Y-1.24%
Book/sh27.86 P/B4.10 EPS next Y9.22% ROA8.00% Target Price122.38 Perf Year15.64%
Cash/sh13.76 P/C8.31 EPS next 5Y8.94% ROE18.70% 52W Range96.44 - 120.10 Perf YTD4.89%
Dividend2.18 P/FCF24.81 EPS past 5Y1.80% ROI11.30% 52W High-4.84% Beta0.88
Dividend %1.91% Quick Ratio2.10 Sales past 5Y3.10% Gross Margin51.40% 52W Low18.51% ATR1.24
Employees29979 Current Ratio2.90 Sales Q/Q5.10% Oper. Margin15.30% RSI (14)38.38 Volatility1.22% 0.95%
OptionableYes Debt/Eq0.74 EPS Q/Q12.20% Profit Margin11.70% Rel Volume1.51 Prev Close114.06
ShortableYes LT Debt/Eq0.70 EarningsJul 31 BMO Payout42.30% Avg Volume638.46K Price114.29
Recom2.60 SMA20-1.56% SMA50-2.22% SMA2000.69% Volume977,300 Change0.20%
01-Aug-14Reiterated Barclays Underweight $115 → $121
09-May-14Reiterated RBC Capital Mkts Sector Perform $109 → $113
07-Apr-14Reiterated ISI Group Buy $123 → $130
09-Jan-14Reiterated Barclays Underweight $106 → $112
05-Nov-13Reiterated Cowen Buy $111 → $117
02-Aug-13Reiterated Barclays Underweight $94 → $106
25-Jun-13Initiated ISI Group Buy $106.50
17-Jun-13Reiterated Argus Buy $95 → $115
03-May-13Reiterated Mizuho Neutral $87 → $96
12-Apr-13Reiterated Deutsche Bank Hold $89 → $94
14-Feb-13Reiterated Argus Buy $87 → $95
06-Feb-13Reiterated Barclays Underweight $82 → $86
22-Jan-13Downgrade Mizuho Buy → Neutral $87
04-Jan-13Reiterated Deutsche Bank Hold $85 → $78
20-Nov-12Initiated Stifel Nicolaus Hold
24-Sep-12Downgrade Barclays Equal Weight → Underweight $76 → $82
21-Jun-11Reiterated Argus Buy $90 → $96
28-Apr-11Reiterated Deutsche Bank Hold $86 → $88
25-Jan-11Reiterated Barclays Capital Equal Weight $78 → $85
18-Jan-11Reiterated Deutsche Bank Hold $79 → $86
15-Sep-14 08:45AM  Steady Growth and Cutting-Edge Technologies Are Trademarks of Pressure BioSciences, Inc. (PBIO) Accesswire
04-Sep-14 04:30PM  BD to Present at the Morgan Stanley Global Healthcare Conference PR Newswire
25-Aug-14 03:32PM  BD - Together with Direct Relief and the National Association of Community Health Centers - Announce Winners of the 2014 BD Helping Build Healthy Communities(SM) Innovations in Care Awards PR Newswire
09-Aug-14 01:04PM  BECTON DICKINSON & CO Financials EDGAR Online Financials
06-Aug-14 08:30AM  BD AutoShield Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes PR Newswire
04-Aug-14 12:15PM  BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report EDGAR Online
10:40AM  BD Expands its Suite of Open System Solutions on the Fully Automated BD MAX Platform PR Newswire
01-Aug-14 07:09PM  Critical Investor John Hussman's Top Five Q2 Holdings Gurufocus
11:58AM  Wall Street Transcript Interview with Terrance H. Gregg, the CEO of Dexcom, Inc. (DXCM) Wall Street Transcript
08:32AM  UPDATE: Deutsche Bank Reiterates On Becton, Dickinson and Co. On Relative Valuation Benzinga
31-Jul-14 02:20PM  Becton, Dickinson Q3 Earnings Meet, Revenues Top Estimates Zacks
08:00AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today CCBN
07:49AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today CCBN
07:15AM  [$$] Becton Dickinson Profit Beats Expectations at The Wall Street Journal
07:07AM  Q3 2014 Becton Dickinson and Co Earnings Release - Before Market Open CCBN
06:17AM  BECTON DICKINSON & CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online<